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1. Introduction 
 
1.1 Aim of the research 
 
The research activities of my doctorate have been devoted to the application of in-cell 
NMR for the characterization of proteins directly inside human cells. Within this 
context, I have also addressed the development of a methodology to perform sequential 
labeling for in-cell NMR in human cells. The in-cell NMR approach, which consists in 
observing one or more selectively labeled protein(s) or nucleic acid in living cells 
through high resolution NMR experiments, is a powerful tool to obtain structural and 
functional information in situ, thus overcoming the limitation of studying 
macromolecules isolated from the other cellular components. Protein folding, post-
translational modifications and interactions with specific partners or cellular elements 
can be studied in the physiological environment in which the protein of interest 
operates.  
My research work also addressed the in vitro characterization of the phosphorylation 
pattern of the non-structural protein 5A domain 3 of Hepatitis C virus by casein kinase 
2. 
 
1.2 In-cell NMR spectroscopy 
 
The cellular interior is packed with macromolecules that differ in their shape, location, 
activity, and ability to interact. A detailed understanding of the biological function of 
macromolecules, such as proteins, DNA, RNA, or their complexes, often requires 
structural knowledge. Biophysical methods for the structural characterization of 
biomolecules are often confined to non native, in vitro experimental setups. X-ray 
crystallography and high-resolution electron microscopy are intrinsically excluded from 
in vivo approaches because of their requirement for pure samples and crystalline or 
vitrified specimens. Due to the samples requirements, the effects of cellular properties 
on biomolecular conformation and dynamics, such as viscosity, molecular crowding, 
and interaction with other macromolecules, as well as the influence of the concentration 
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of ions and other small molecules cannot be analyzed [1-4]. Nuclear magnetic 
resonance (NMR) spectroscopy, the only other method for structural investigations at 
atomic level, allows for the direct and selective observation of NMR-active nuclei 
within any NMR-inactive environment. The noninvasiveness of NMR spectroscopy, 
and its ability to study biological macromolecules at physiological temperatures, led to 
the establishment of the in-cell NMR approach in 2001 that allows for the investigation 
of the structural behavior of isotopically labeled proteins inside living bacterial cells   
[5, 6]. Since then, the approach has been extended to several other cellular systems, 
including Xenopus laevis oocytes, yeast, insect cells and mammalian cells, to study the 
conformation of biological macromolecules in their natural environment [7-11]. 
The ability to detect changes in the conformation of a macromolecule between the in 
vitro situation and the interior of living cells is based on the sensitivity of the NMR 
chemical shift to be affected by the structural properties. Changes in the conformation, 
but also binding of small or large molecules and post-translational modifications, 
translate in NMR chemical shifts. 
 
Detection of a particular macromolecule in the crowded intracellular environment 
requires that this macromolecule is labeled with (i.e. enriched in) NMR-active isotopes. 
Labeling with the isotopes 
13
C (1.1% natural abundance) and 
15
N (0.36% natural 
abundance) has proven to be the method of choice to filter out the background signals 
arising from all the hydrogen atoms of the cell, and enable the extraction of information 
on the macromolecule of interest. In particular, 2D [
1
H,
 15
N]-HSQC, which measures 
the chemical shifts of the amide hydrogen and nitrogen atoms, easily and efficiently 
provides information about the conformation of the protein backbone. Two strategies 
can be pursued to produce a cell sample containing the labeled protein of interest: 
delivery of a heterologously expressed, purified protein inside the cell or overexpression 
of the protein directly in cells. In the case of protein delivered into cell system, the 
cellular background signals contain only signals due to the 
13
C and 
15
N natural 
abundance. If, however, labeling occurs within the cellular system also used for the 
NMR spectroscopic experiments, not only the macromolecule of interest, but also other 
cellular components will be labeled. To increase the labeling selectivity, the expression 
of the protein has to occur as quickly as possible and the cell growth must be slow down 
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expression time. 
15
N-labeling produces only a small number of background signals, 
whereas 
13
C-labeling creates strong background peaks that make unambiguous 
identification of resonance of the macromolecules of interest difficult. The higher 
background level in the case of 
13
C-labeling respect to 
15
N-labeling is due to the higher 
number of C-H groups in biomolecules than of N-H groups and to the fact that N-H 
groups exchange with water while C-H groups do not. Amino acid type selective 
labeling of proteins can also apply for in-cell NMR experiments. Unfortunately, not all 
amino acids can be used for selective labeling procedures. Good candidates are those at 
the end of a biosynthetic pathway, which therefore are not needed as precursors for 
other amino acid synthesis. 
A significant challenge in the application of in-cell NMR is the inherent insensitivity of 
NMR spectroscopy and the consequent need of high effective concentration             
(10–250 µM) of the macromolecules under study. These concentrations are typically 
several orders of magnitude higher than the native concentrations of the macromolecule 
of interest (0.5–1 µM).  
To observe of a solution [
1
H, 
15
N]-HSQC spectrum of the protein of interest, it is 
necessary that the macromolecule tumbles freely in solution with a sufficient short 
correlation time. Several investigations have shown that viscosity reduces the rotational 
diffusion by a factor of 2–3 in most eukaryotic cell types and of 10-11 in Escherichia 
coli (E. coli) cells relative to measurements in water, resulting in an increase of the 
apparent molecular weight of the biomolecule roughly by the same factor [6, 12-14]. 
However, interactions with other large cellular components, such as macromolecular 
complexes, nucleic acids, or membranes, can dramatically slow down the average 
tumbling rate, thus resulting in broad or even undetectable resonance lines [15, 16].  
Intrinsically disordered proteins (IDPs) show often weaker interactions with their 
surroundings and can compensate the concomitant reduction in their tumbling rate with 
their inherently high internal flexibility [17-20]. In contrast, the backbone resonances of 
many globularly folded proteins are not detectable, thus suggesting that their tumbling 
rates are significantly slower in vivo, most likely as a result of nonspecific interactions 
with other cellular components [15, 16, 21-23]. One way to visualize these proteins in 
the cellular environment is to perform selective labeling of methyl groups, which can be 
detected more readily because of their fast internal rotation [24]. Besides weak 
nonspecific interactions with other cellular components, the loss of signals in in-cell 
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NMR experiments can also be caused by the formation of large specific complexes, 
degradation, or conformational exchange. Specific- complex formation is in most cases 
unlikely, as the macromolecule under NMR investigation is typically several orders of 
magnitude higher than the cellular concentration of a specific binding partner. The 
degradation of macromolecules was mainly observed in in-cell NMR experiments on 
nucleic acids [25, 26]. Finally, signal loss can also occur as a result of conformational 
exchange processes [27].  
Another critical parameter that influences the applicability of in-cell NMR experiments 
is the survival time of the cells in the NMR tube; the cells have to remain viable at least 
for the time period of the measurements. The high cellular density inside the NMR tube 
can cause oxygen starvation and limits the amount of available nutrients. If the 
experimental sensitivity and the protein concentration are sufficiently high, the NMR 
spectra can be measured relatively quickly (in less than one hour). Cells can be kept 
alive for longer times in the NMR instrument if the sample holder is modified to allow 
for the constant exchange of the medium to supply fresh nutrients as well as oxygen 
[28].  
Since the first in-cell NMR experiments [5], E. coli has been one of the most used cell 
type, due to the advantages of working with bacteria (for example, their rapid growth 
rates, robustness and high recombinant protein expression levels) (Fig. 1a). Several 
applications for structural and functional studies of proteins overexpressed in bacteria 
have been reported: studies of macromolecular crowding [15, 29], protein structure and 
folding [27, 30-34], protein-protein interactions [35, 36] and interactions with drugs    
[9, 37], nucleic acids [38], or other cellular components [15, 23]. The structure of 
TTHA1718 protein was solved from in-cell NMR data obtained in E. coli cells [31]. 
Bacterial cells could be used as a model for the cytoplasm, but they lack 
compartmentalization, opposite to eukaryotic cells, and are unable to do post-
translational modifications that are crucial for the function of many eukaryotic proteins.  
Therefore, in-cell NMR on eukaryotic cells is a necessary step forward. Methods have 
been developed to observe proteins in live eukaryotic cells by NMR, which rely either 
on the insertion of pure, isotopically labeled proteins (produced in E. coli) from outside 
the cells, or on the overexpression of the protein directly inside the cells. The first 
eukaryotic cells used in in-cell NMR experiments were Xenopus laevis oocytes [7]. The 
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main advantage of X. laevis oocytes is their large size (ca. 1 mm in diameter), which 
allows microinjection of the protein or nucleic acid of interest into the citosol (Fig. 1b). 
Advantages of this approach for protein insertion in the cell are a better control on the 
intracellular protein concentration, the ability to isotopically label specific sites of the 
macromolecule, and the ability to introduce modifications, such as paramagnetic spin 
labels, which are difficult to introduce through the overexpression mode. X. laevis 
oocytes have been used to study phosphorylation of folded and intrinsically disordered 
proteins and to investigate the conformation of nucleic acids [18, 25, 26, 39-41]. 
When working with cultured mammalian cells, microinjection is not an option, owing to 
the small size of these cells compared to oocytes and therefore other methods had to be 
developed to enable the required high intracellular concentration to be attained. One 
procedure consists in tagging, through disulfide bonds, the protein of interest with a 
cell-penetrating peptide (CPP) that delivers the system into the cytoplasm (Fig. 1c). The 
protein is subsequently released from the CPP by endogenous enzymatic activity or by 
autonomous reductive cleavage [9, 42]. Although the mechanism of protein delivery 
with CPPs is not fully understood, a key molecular determinant is net charge [43]; as 
long as the CPP carries a sufficient amount positive charge to override the net charge of 
the cargo, its detailed amino-acid composition seems to be of secondary importance. 
Therefore, constructs with a negative or zero net charge can be efficiently delivered by 
CPPs into mammalian cells only by rational alteration of the net charge. Another 
method to insert an isotopically labeled protein into the cytosol was developed by Ogino 
et al. They took advantage of the pore-forming toxin streptolysin O to insert the protein 
thymosin β4 in human 293F cells (Fig. 1d). One attractive feature of this approach, in 
contrast to the CPP strategy, is that no modifications to the protein are required for 
intracellular sample delivery [8]. In-cell NMR spectra are thus uncompromised by CPP 
tags or by additional amino acids that remain present after intracellular tag removal. 
One disadvantage is the requirement for mammalian cells that grow in suspension and 
for highly soluble target proteins. Because the amount of delivered sample depends on 
passive diffusion through the toxin pore, and not on an active uptake process like the 
CPP case, the protein concentration gradient across the cell membrane directly relates to 
the overall transduction efficiency. Recently, protein electroporation has been 
developed, which consists in applying an electric pulse to cells so to increase 
permeability of extracellular membrane by pore formation, and to insert the purified 
6 
 
protein of interest into the cytosol (Fig. 1e) [44, 45]. This method is suitable to deliver 
native proteins, without requirements for engineered protein tags or targeting sequences, 
and not require any treatment of cells with toxic compounds, which decrease cell 
viability and signal the activation of damage response pathways. Shekhtman et al. used 
this technique to probe weak protein (quinary) interactions inside the cytoplasm of 
HeLa cells.  
In addition to deliver the protein of interest into cytoplasm, it is possible to produce    
in-cell NMR sample also by overexpressing a labeled protein directly inside eukaryotic 
cells. In-cell NMR in the yeast Pichia pastoris was applied to study the influence of 
metabolic changes on protein structure and dynamics at atomic resolution (Fig. 1f) [11].  
Hamatsu et al. have shown that insect cells are also amenable to in-cell protein NMR by 
exploiting a baculovirus expression system, reporting both [
1
H, 
15
N]-HSQC spectra and 
three dimensional spectra of four small globular proteins, including GB1 and 
calmodulin (Fig. 1g) [10]. In order to study the various maturation steps of a human 
protein right after protein biosynthesis, including post-translational modifications, and 
investigate the interactions with specific partners it is necessary to overexpress the 
protein of interest directly inside human cells [46]. Banci et al. have developed a 
method to overexpress one or more proteins in human embryonic kidney cells 
(HEK293T) by transient transfection. Protein overexpression levels could be controlled 
by varying the amount of transfected DNA (Fig. 1h). To reach high transfection 
efficiency, plasmids were complexed with polyethylenimine (PEI) prior to transfection. 
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Figure 1 Overview of prokaryotic and eukaryotic in-cell NMR systems. (a) Accumulation of isotope-labeled protein 
inside Escherichia coli by T7 promoter–driven overexpression. (b) Delivery of isotope-labeled proteins by 
microinjection into Xenopus laevis oocytes. (c) Transduction of cell-penetrating peptide (CPP)-tagged (cyan) cargo 
proteins into cultured mammalian cells. (d) Delivery of isotope-labeled proteins into mammalian cells through 
bacterial pore-forming toxins (blue). (e) Delivery of isotope-labeled protein into cultured human cells by 
electroporation. (f) AOX1-driven protein production in the yeast Pichia pastoris. (g) Baculovirus (BV)-infected 
insect Sf9 cells. (h) Cytomegalovirus (CMV) promoter– driven protein overexpression and isotopic labeling in 
human HEK293T cells. Cells are not drawn to scale. Adapted from [44, 47]. 
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1.3 Mia40 
 
Mia40 (Mitochondrial intermembrane space import and assembly protein 40) is an 
oxidoreductase, located in the mitochondrial intermembrane space (IMS), that imports 
and traps proteins in the IMS through oxidative protein folding [48, 49]. The IMS of 
mitochondria, the compartment between the mitochondrial outer and inner membrane, 
harbors many proteins that perform important functions in cellular processes, such as 
generation of ATP by oxidative phosphorylation, synthesis of iron sulfur clusters, 
apoptosis, transport of metabolites and proteins across the IMS and detoxification from 
reactive oxygen species. Except for a few proteins of the inner membrane and the 
mitochondrial matrix, all mitochondrial proteins are synthesized in the cytoplasm from 
nuclear DNA [50-52] and have to cross the outer membrane through a translocation 
complex of outer membrane (TOM) [50]. Some precursors of IMS proteins contain 
bipartite targeting information in their N-terminal region: a presequence-type matrix 
targeting signal followed by a hydrophobic sorting signal, which arrests the 
translocation at the translocase inner membrane (TIM23) complex. Through a 
subsequent proteolytic step, the mature protein is released into the IMS. A family of 
small IMS proteins is synthesized without a cleavable presequence, but contain 
conserved cysteine residues arranged in a coiled-coil-helix-coiled-coil-helix (CHCH) 
folding domain [50]. They contain twin -CXnC- cysteine motifs and are imported 
through the TOM channel as reduced, unfolded polypeptides. In the IMS, these proteins 
interact with Mia40, which induces folding and oxidation through the formation of 
intramolecular disulfide bonds. Once oxidized and folded, they are unable to cross the 
outer membrane back, and therefore they are trapped in the IMS [53]. Among these 
small IMS proteins are Cox17, which is a copper chaperone essential for delivering 
Cu(I) through interaction with Sco1, Sco2 and Cox11 to the CuA site of cytochrome c 
oxidase [54-56], and the small Tim proteins, which are chaperones essential for import 
and maturation of mitochondrial integral membrane proteins [57, 58]. 
Mia40 is a 16 kDa protein with a CHCH structure analogous to its substrates and it 
harbors six conserved cysteines forming three disulfide bonds. Two of them are formed 
across the twin -CX9C- motifs between Cys64-Cys97 and Cys74-Cys87 and have a 
structural role. In the mature form of Mia40, they hold together two alpha-helices 
forming an antiparallel α-hairpin (α2 residues 65-77 and α3 residues 88-100) [59, 60]. 
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The third disulfide bond is formed by Cys53-Cys55 and constitutes the catalytic CPC 
redox site (Fig. 2). This is crucial for the oxidation of the reduced substrates. Thus in 
mitochondria, Mia40 cycles between two redox states: the fully oxidized one    
(Mia40
3S-S
) containing three intramolecular disulfide bonds, and the partially reduced 
form where the CPC is reduced (Mia40
2S-S
).  
 
Figure 2 Solution structure of the folded Mia402S-S. Ribbon diagram of the lowest-energy conformer of Mia402S-S. 
Helix α1 of the N-terminal lid is shown in red, and helices a2 and a3 composing the a-hairpin core are shown in blue 
and cyan. Disulfide pairings (or free thiols) are shown in yellow. From [59]. 
 
Mia40 is synthesized in the cytoplasm and needs to be in a fully reduced and unfolded 
state in order to translocate to the IMS through the TOM channel. Therefore, Mia40 
must remain unfolded and completely reduced during its entire journey through the 
cytoplasm, until it is imported into mitochondria. It has been demonstrated that Mia40 is 
imported into the IMS through the same pathway of its substrates, and in the IMS it is 
oxidized by pre-existing Mia40, in a self-propagating manner [61-63]. 
Mia40 interacts with its substrates, after they enter the IMS in the unfolded reduced 
state, through hydrophobic interaction between the hydrophobic cleft on Mia40 and an 
internal targeting signal (ITS) present on the substrate [64]. This interaction orients the 
substrate in a way to expose a cysteine side chain to the active CPC site of Mia40, 
where a mixed disulfide bond is formed between the substrate cysteine and the docking 
Cys55 of Mia40. It has been demonstrated by NMR experiments that covalent binding 
to Mia40 induces formation of first α-helix in the substrate, thus demonstrating the 
chaperone role of Mia40 [60]. Upon isomerization of the S-S intermolecular bond, the 
first disulfide bond is formed in the substrate inducing the folding of the second α-helix 
and the release from Mia40, which is now CPC-reduced (Fig. 3). The reduced active 
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site of Mia40 is re-oxidized by reaction with the Augmenter of Liver Regeneration 
protein (ALR) a FAD-linked thiol oxidase, which in turn shuttles electrons to 
cytochrome oxidase (and eventually to O2) via reaction with cytochrome c [65, 66]. 
Together form the disulfide relay system of the IMS of mitochondria [67]. The 
generation of the second disulfide bond in the substrate could follow different routes 
depending on the substrate and on different cellular condition. This disulfide can be 
formed upon oxidation by oxygen and other small oxidant or upon the formation of a 
ternary complex among substrate, Mia40 and ALR [68]. 
 
Figure 3 Steps of the oxidative folding mechanism of CHCH domain-containing proteins in the IMS. Substrates of 
the oxidative folding pathway are imported in the IMS through the TOM channel in the unfolded state. Upon 
interaction with Mia40, an intermolecular disulfide bond is formed, inducing the formation of the first α-helix. The 
oxidized substrate is then released from Mia40. From [60]. 
 
1.4 Non structural protein 5A  
 
The non structural protein 5A (NS5A) is a phosphoprotein without any enzymatic 
activity that plays key roles in both genome replication and virion assembly/release of 
Hepatitis C virus (HCV). HCV virus chronically infects approximately 130-150 million 
people worldwide (http://www.who.int/mediacentre/factsheets/fs164/en/). Acute 
infections are often asymptomatic and are spontaneously cleared within several weeks. 
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Persistent, or chronic, infections are defined by detection of HCV RNA in the blood for 
6 months or more after infection. It is estimated that up to 85% of all HCV infections 
progress to chronicity, causing fibrosis which ultimately leads to cirrhosis, end-stage 
liver disease, and/or hepatocellular carcinoma [69, 70]. Six closely related viral 
genotypes, classified by sequence homology, comprise the HCV genus [71]. Genotype 
1 is the most abundant worldwide, and includes subtypes 1a and 1b [72]. The traditional 
standard of care (SOC) for HCV-infected patients has been limited to a regimen of 
pegylated-interferon alpha (pegIFN) and ribavirin; displaying low cure rates in a 
majority of patients and severe side effects [73, 74]. However, in 2011 the first direct-
acting antivirals (DAA) were licensed to treat HCV-infected patients in combination 
with SOC, which served to elevate treatment response rates [75]. The HCV drug 
development pipeline is currently populated with many additional and improved DAAs; 
primarily molecules that target the virus-encoded protease, polymerase enzymes or non 
structural proteins (http://www.uptodate.com/contents/direct-acting-antivirals-for-the-
treatment-of-hepatitis-c-virus-infection) but their mode of action is still not well 
understood. Therefore, a better understanding of the molecular mechanisms involved in 
the HCV life cycle is required to develop new antiviral therapies. 
HCV is an enveloped virus, belonging to Flaviviridae family, containing a positive-
sense, single-stranded RNA genome of about 9.6-kb [76]. The RNA genome codes for 
an ~3,000 amino acids polyprotein that is cleaved co- and posttraslationally by both host 
and viral proteases to produce 10 mature viral proteins: the structural proteins, Core, E1 
and E2, which make up the virus particle; the viroporin p7, which has roles in virus 
assembly and release, and the nonstructural (NS) proteins NS2, NS3, NS4A, NS4B, 
NS5A, NS5B, which are involved in both genome replication and virion assembly    
[77, 78]. 
NS5A plays a critical role in RNA replication and particle assembly, however the 
precise nature of these two functions of the protein and how they are regulated remain 
to be elucidated [79]. NS5A consists of three domains linked by two low complexity 
sequences (LCS-1 and LCS-2) and an amino-terminal amphipathic helix essential for its 
membrane association (Fig. 4) [80, 81].  
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Figure 4 Schematic representation of the domain organization of NS5A. Ribbon representations of the N-terminal 
amphipathic helix (AH, blue, PDB entry 1R7E) and dimeric globular domain 1 (D1, pink and blue, PDB entry 
3FQM) are shown. Reprinted from [82]. 
 
Domain 1 (D1) comprises a zinc-binding motif, which is essential for HCV RNA 
replication [83] and forms a homodimer with a large RNA binding groove located at the 
interface of the monomer  [84, 85]. It is also required for the interaction with lipid 
droplets, the organelles where the assembly of infectious particles starts [86]. Domains 
2 and 3 (D2, D3) have been shown to be both intrinsically disordered with a propensity 
to form secondary structure elements [87-89]. D2 is essential for RNA replication, 
while D3 is thought to be dispensable for that role [90, 91]. It has been shown, however, 
that D3 is critical in the virus assembly process, as it is required for the interaction 
between NS5A and the core protein [92]. 
NS5A exists in two forms with slightly different mobility on an SDS-PAGE gel: a 
basally phosphorylated form (apparent molecular mass of 56 kDa) and a 
hyperphosphorylated form (58 kDa) [93, 94]. Pulse-chase and mutational analysis 
suggest that both phosphorylated forms are produced after completion of the proteolytic 
cleavages at the N- and C-termini of NS5A, and that p58 is the product of p56 
hyperphosphorylation. Hyperphosphorylation sites have been identified in a serine-rich 
region in LCS-1 and in D2, and have been shown to act as negative regulators of the 
RNA replication process [94-97]. It has been demonstrated that hyperphosphorylation 
of NS5A requires NS3, NS4A and NS5B [98].The cellular kinases that are mainly 
involved in the generation of the p58 form are the α isoform of casein kinase 1 (CK1-α) 
[99] and polo-like kinase 1 (Plk1) [100]. Suzuki et al. suggested that CK1-α 
phosphorylates NS5A on S225 and S232 [101]. It has been demonstrated that also S222 
is involved in hyperphosphorylation form of NS5A but actually the responsible kinase 
has not been identified [97, 102]. The basally phosphorylated sites are mainly serine 
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residues located in both D2 and D3 [94-97]. The basal phosphorylation of D3 plays a 
critical role in the virion assembly, as serine to alanine mutations and/or deletions of 
parts of D3 have been shown to disrupt the interaction with core protein and impair the 
production of infectious virions [92, 103]. It has been shown that casein kinase 2 (CK2) 
is responsible for the basal phosphorylation of D3 in multiple sites [104, 105]. Potential 
CK2 phosphorylation sites were identified but only one residue (Serine 457 in 2a JFH-1 
genotype) was confirmed [103, 106]. 
Mechanisms regulating NS5A phosphorylation and its exact function in the HCV life 
cycle have not been clearly defined. Hyperphosphorylated NS5A form was 
predominantly localized in low-density membrane structures around lipid droplets, in 
which NS5A interacts with the core for virion assembly, while reduction of NS5A 
hyperphosphorylation led to a decrease in NS5A abundance in the low-density 
membrane structures. This suggests that NS5A-associated kinases and NS5A 
phosphorylation have a regulatory role in the viral life cycle especially as a molecular 
switch governing the transition between viral replication and virion assembly [101]. 
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2. Results 
 
2.1 Visualization of Redox-Controlled Protein Fold in 
Living Cells 
 
The folding and oxidation states of Mia40 were investigated as a function of the sample 
conditions in the human cell cytoplasm by in-cell NMR. In this cellular compartment, 
Mia40 need to be in the reduced, unfolded state. However, when it is overexpressed in 
HEK293T cells cytoplasm, it is present in a folded and in disulfide-oxidized state as 
monitored through 2D 
1
H,
15
N-SOFAST-HMQC and 
1
H NMR spectra. This suggested 
that some thiol-disulfide regulation mechanism is necessary to keep Mia40 reduced in 
the cytoplasm until it reaches the outer membrane.  
Co-expression with glutaredoxin 1 (Grx1) and thioredoxin 1 (Trx1), two cytoplasmic 
oxidoreductases involved in the regulation of the oxidation state of protein thiol groups 
influenced the ratio between folded and unfolded species of Mia40. When Mia40 was 
co-expressed with various amounts of Grx1, a large fraction of Mia40 was present in the 
reduced, unfolded state. This effect was confirmed by a decrease of the methyl signal at 
-0.7 ppm, used as a marker of the folded state of Mia40, and the total amount of protein 
was determined by Westerm Blot. In presence of increasing amounts of Grx1, oxidized 
Mia40 (Mia40
2S-S
) in the cytoplasm decreased to ~25% of the total Mia40. 
The effect of Trx1 on Mia40 state was also investigated, by inducing co-expression of 
Trx1 with Mia40. Co-expression of Trx1 affected the folding state of Mia40 to a lesser 
extent than Grx1 when expressed at similar levels, as ~50% of cytoplasmic Mia40 was 
still in the folded, oxidized state. Therefore, the two proteins have different efficacy in 
keeping Mia40 reduced, despite being reported to have overall similar functions in the 
cytoplasm. 
 
 
 
15 
 
 
 
16 
 
 
 
17 
 
 
 
18 
 
 
 
19 
 
 
 
20 
 
 
 
21 
 
Chemistry & Biology, Volume 20 
 
Supplemental Information 
 
Visualization of Redox-Controlled Protein Fold 
in Living Cells 
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Inventory of Supplemental Information 
Figure S1: WB analysis of cytoplasmic and mitochondrial fractions of cell samples 
overexpressing Mia40, Grx1 or Trx1, which allowed their subcellular localization to be 
assessed; dot blot analysis of endogenous levels of Mia40, Grx1 and Trx1 (related to 
Figure 1). 
 
Figure S2: NMR spectra showing the folding and redox states of Mia40 in vitro, which 
are used as a reference to analyze the folding state of cytoplasmic Mia40 (related to 
Figure 2). 
 
Figure S3: NMR spectra showing that intracellular Grx1 and Trx1 are not detectable 
by NMR, and only become visible in the cell extracts (related to Figure 3). 
 
Figure S4: MALDI mass spectrometry analysis of Mia40 isolated from cell extracts 
and in vitro Mia40 samples, in which is shown the absence of glutathionylated forms of 
Mia40 (related to Figure 3). 
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Supplementary Figures: 
 
 
 
 
Figure S1, related to Figure 1: Overexpressed Mia40, Grx1 and Trx1 are mostly 
localized in the cytoplasm; Grx1 and Trx1 are fully reduced. (A) Cytoplasmic and 
mitochondrial fractions of cells were blotted at increasing dilutions to assess the 
intracellular distribution of overexpressed Mia40, Grx1 and Trx1. Dilutions are 
expressed relative to the most concentrated mitochondrial extract. The subcellular 
fractions were obtained using a mitochondria isolation kit for cultured cells (Thermo 
Scientific). The fraction purity was checked with a mitochondrial and a cytoplasmic 
marker (COX IV and GAPDH, respectively). (B) Endogenous levels and subcellular 
localization of Grx1 and Trx1 were measured by dot blot analysis of cytoplasmic and 
mitochondrial extracts. Pure samples at known concentration were blotted as a 
reference. (C) AMS thiol alkylation reaction on a cell extract containing overexpressed 
Grx1 was detected by Western Blot, showing that all Grx1 cysteines are reduced. 
Purified Grx1 was run as a reference. The same reaction was performed on a cell extract 
containing Trx1 overexpressed in presence of fully active TrxR, showing that all Trx1 
cysteines are reduced. 
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Figure S2, related to Figure 2: Oxidized, folded Mia40 is reduced in vitro upon 
heat denaturation in reducing conditions. 
1
H-
15
N SOFAST HMQC spectra were 
acquired on pure U-
15
N Mia40
2S-S
 (A) before and (C) after denaturation at 95°C in 
presence of 10 mM GSH. After denaturation, the crosspeaks of the N- and C-terminal 
unfolded segments of Mia40 are still visible (with sharper lines), while those 
corresponding to the core segment of oxidized Mia40 disappear. AMS reaction was 
performed on Mia40 samples before and after denaturation, which were run on 
Coomassie-stained SDS-PAGE (B, D), confirming the reduction of the two structural 
disulfide bonds.  
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Figure S3, related to Figure 3: The amide signals of cytoplasmic Grx1 and Trx1 
are broadened beyond detection. 
1
H-
15
N SOFAST-HMQC spectra were acquired on 
samples of human cells expressing (A) Grx1 and (C) Trx1, and on the corresponding 
cell extracts (B, D). Only the cellular background signals were visible in the spectra of 
intact cells, where the amide crosspeaks of Grx1 and Trx1 are broadened beyond 
detection. Upon cell lysis, the crosspeaks of both proteins were detected. 
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Figure S4, related to Figure 3: Mass spectrometry analysis shows absence of 
glutathionylated Mia40. MALDI TOF/TOF analysis of Mia40 isolated from cell 
extracts (native Mia40) and Mia40 in vitro samples (GSFT-Mia40). (A) Extract of cells 
overexpressing Mia40 alone; (B) extract of cells co-expressing Mia40 and Grx1; (C) in 
vitro Mia40 heat denatured in 20 mM GSH (phosphate buffer, pH 7), after removal of 
GSH; (D) same sample as (C), incubated with 2 eq. of Grx1 in 20 mM GSH, after 
removal of GSH. Points in the spectra corresponding to increasingly glutathionylated 
forms of Mia40 are indicated (+305.3 Da for each GSH molecule). 
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2.2 Sequential protein expression and selective labeling 
for in-cell NMR in human cells 
 
When the genes encoding two proteins are transiently co-transfected, both proteins are 
overexpressed and labeled at the same time. In order to effectively characterize protein-
protein interactions in mammalian cells, the in-cell NMR signals of only one partner 
need to be detected. This requires the selective labeling of only one protein. A way to 
reach this goal is the overexpression of a protein in a transient way while the other is 
constitutively overexpressed by the cells. Stable HEK293T cell lines overexpressing 
HAH1, a cytosolic copper chaperone protein were established. The HAH1 expression 
levels were checked for each cell line by Western Blot analysis, and the one with the 
highest levels was chosen. To test the protocol, the stable cell line was grown in 
unlabeled medium and was transiently transfected with either SOD1 or Trx1 (whose 
signals are not detectable due to interactions with the cellular environment) in            
[U-
15
N]-labeled medium. In either case, the NMR signals of 
15
N-HAH1 were still 
detected, due to HAH1 being continuously expressed together with the second protein 
and therefore becoming labeled to some extent. A possible way to increase the labeling 
selectivity is to decrease the expression rate of HAH1 during the transient transfection, 
by exploiting the RNA interference (RNAi) machinery of the cell to silence the HAH1 
gene, and by performing the medium switch after the silencing has taken place. We 
used a transcription plasmid (pSilencer vector) that it is able to produce a shRNA 
specific against the mRNA of HAH1. We prepared three pSilencer vectors, each 
encoding a different shRNA sequence, and we tested them by checking the HAH1 
expression level in stably transfected cells. The relative levels of HAH1 mRNA were 
assessed by RT-PCR analysis, and we verified that after 24 hours of silencing a 
combination of the three shRNA sequences had higher efficiency compared to each 
sequence alone. The HAH1 mRNA and protein levels were checked respectively by 
RT-PCR and Western Blot at different times after the transfection, ranging from 6 to 72 
hours. A useful time window to perform the medium switch and the labeling of the 
transiently expressed protein was found, from 14 to 30 hours after the transfection, in 
which the HAH1 gene was silenced while the protein levels did not decrease much due 
to protein turnover. NMR experiments were performed on cells where the stably 
expressed HAH1 was silenced and SOD1 was transiently expressed, keeping the cells in 
unlabeled medium for 14 hr and 16 hr in 
15
N-labeled medium. In the 
1
H-
15
N SOFAST-
27 
 
HMQC spectra, only the signals of SOD1 were detected in both cells and lysate 
samples. In the 1D 
1
H NMR spectra, we verified that the total final levels of HAH1 
were ~70% of the control sample with no silencing. This approach can be a useful tool 
for the characterization of protein-protein interactions, allowing the detection of the 
NMR signals of only one intracellular partner. 
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Abstract 
Background: In-cell NMR is a powerful technique to investigate proteins in living cells 
at atomic resolution, especially when applied to human cells. Ideally, when studying 
functional processes involving protein-protein interactions by NMR, only one partner 
should be isotopically labeled. Here we show that constitutive and transient protein 
expression can be combined together with protein silencing to obtain selective protein 
labeling in human cells. 
Methods: We established a human cell line stably overexpressing the copper binding 
protein HAH1. A second protein (human superoxide dismutase 1, SOD1) was 
overexpressed by transient transfection and isotopically labeled. A silencing vector 
containing shRNA sequences against the HAH1 gene was used to decrease the rate of 
HAH1 synthesis during the expression of SOD1. The levels of HAH1 mRNA and 
protein were measured as a function of time following transfection by RT-PCR and 
Western Blot, and the final cell samples were analyzed by in-cell NMR. 
Results: SOD1 was ectopically expressed and labeled in a time window during which 
HAH1 biosynthesis was strongly decreased by shRNA, thus preventing its labeling.    
In-cell NMR spectra confirmed that, while both proteins were present in the sample, 
only SOD1 was selectively labeled and could be detected by 
1
H-
15
N heteronuclear 
NMR. 
Conclusions and General Significance: We showed that controlling protein expression 
by specifically silencing a stably expressed protein is a useful strategy to obtain 
selective labeling of only one protein. This approach relies on established techniques 
thus permitting the investigation of protein-protein interactions by NMR in human cells. 
Keywords: in-cell NMR; nuclear magnetic resonance; protein-protein interactions; 
isotopic labeling; mammalian cells. 
 
Introduction 
In-cell NMR spectroscopy has been proven to be an ideal technique to obtain atomic-
level structural and functional information on biological macromolecules directly in 
living cells, i.e. in their native environment (1-3). The data obtained by in-cell NMR are 
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likely closest to the physiological conditions than any other atomic-resolution 
technique. In-cell NMR allows physiological processes to be investigated such as 
protein folding and misfolding (4–6), interactions with other proteins or nucleic acids 
(7–10), binding of metal ions (11–13), and ligand screening (14). Most of the initial 
works focused on proteins overexpressed in E. coli cells, due to the high protein levels 
attainable and to the ease of growing and handling the cells. Although bacterial cells are 
considered a good model to investigate cytoplasmic proteins, they lack many cellular 
machineries for protein folding and post-translational modifications, which are crucial 
for the correct maturation of many eukaryotic proteins. Due to such limitations of the 
bacterial models, in-cell NMR in eukaryotic cells is a necessary step forward for 
studying proteins in their native environment. Several approaches have been developed 
to deliver a purified labeled protein into the cytoplasm of eukaryotic cells, including 
microinjection in X. laevis oocytes (15), fusion with cell-penetrating peptides (16), and 
cell permeabilization either through pore-forming toxins (17, 18) or by cell 
electroporation (19, 20). Alternatively, methods have been developed to overexpress the 
protein of interest directly into eukaryotic cells, and have been applied to yeast and 
insect cells (21, 22) and to cultured human cells (13).  
Protein overexpression in human cells has been used to follow the various steps of 
protein maturation right after protein biosynthesis, including folding and metal binding 
(5, 13, 23), changes in redox state (24), and targeting towards cellular compartments 
such as mitochondria (25). With the same approach, ectopic co-expression of two or 
more proteins has permitted to observe the effects of functional interactions with 
specific partners on the protein of interest (5, 13, 24). The employed strategy for protein 
co-expression causes the two (or more) proteins to be expressed simultaneously by the 
cells, and does not allow any labeling selectivity between them. Therefore, as soon as 
the isotopically enriched medium is provided, all the expressed proteins are equally 
labeled, and are detected in the in-cell NMR spectra. Ideally, when studying 
biomolecular interactions by NMR, only one partner should be labeled in order to allow 
the correct interpretation of any spectral changes upon interaction. In bacterial cells, 
methods have been developed for this purpose, in which orthogonal induction systems 
are used for two or more proteins, allowing them to be expressed at different times and 
with different labeling (7, 8). To date, similar approaches that permit sequential protein 
expression and labeling in human cells are lacking. 
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Here we show that constitutive and transient protein expression can be combined with 
protein knock-down by gene silencing to allow two human proteins to be expressed at 
different times in human cells, permitting selective isotopic labeling of one protein. This 
novel methodological approach was tested and optimized on two human proteins that 
have been extensively characterized by NMR both in-cell and in vitro: HAH1 (26, 27) 
and SOD1 (5, 11, 13, 28, 29). We are confident that this novel experimental procedure 
will enable the study of protein-protein interactions in mammalian cells by NMR.  
 
Materials and Methods 
Gene cloning 
The gene encoding full-length human HAH1 (amino acids 1-68, GenBank accession 
number: NP_004036.1) was amplified from cDNA by PCR and cloned in the pURD 
vector (kindly provided by Y. Zhao, University of Oxford) (30) between HindIII and 
XhoI restriction enzymes. Three sequences of small hairpin RNA (shRNA) were 
designed to perform silencing of HAH1, in the form of sense-loop-antisense sequences 
(31, 32). One sequence, shRNA-1, targets the HAH1 open reading frame (5’-
GACGAGTTCTCTGTGGACATGACGAATCATGTCCACAGAGAACTCGTTT
TTTTGGAA-3’; sense and antisense sequences are shown in bold) while other two 
target unique UTR elements present in the pURD vector: shRNA-2 targets the 
woodchuck hepatitis virus post-transcriptional regulatory element (WPRE: 5’-
GCAATCAACCTCTGGATTACACGAATGTAATCCAGAGGTTGATTGCTTT
TTTGGAA-3’); shRNA-3 targets the bovine growth hormone polyadenylation signal 
(bGHpA: 5’-
GGAAGACAATAGCAGGCATGCCGAAGCATGCCTGCTATTGTCTTCCTTT
TTTGGAA-3’). The corresponding synthetic double stranded DNA oligonucleotides – 
flanked by compatible ends for BamHI and HindIII restriction sites – were individually 
cloned in the pSilencer 2.1-U6 Hygro vector (Life Technologies) following the vector 
manual. pHLsec-derived vectors containing the cDNA encoding the full-length human 
SOD1 (pHLsec-SOD1) and the full-length human thioredoxin 1 (pHLsec-TRX1) were 
used for transient expression as previously described (13). 
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Generation of stable cell lines 
HEK293T-derived cell lines stably overexpressing HAH1 were obtained following a 
reported protocol (33). Parental 293T cells (ATCC CRL-3216) were transfected in a    
6-well dish with the pURD vector containing the HAH1 cDNA, together with the 
PhiC31 integrase gene (pgk-phiC31/pCB92) in a 1:3 (HAH1:phiC31) ratio, to facilitate 
integration into the host cell genome. The following day the cells were seeded into a   
15 cm dish, and let grown for the next 5 days. Once they reached ~100% confluence, 
stable cell line selection was performed by treating the cells with 2 µg/ml puromycin for 
10 days, replacing the growth medium every 3-4 days to remove dead cells, until cell 
clumps (single colonies) were visible. Single colonies were manually picked from the 
dish and individually seeded 96-well plate wells. During the following days, 36 growing 
colonies (H1 – H36) were selected by manual inspection and seeded to 12-well plates. 
12 lines out of these were selected based on the growth rate, and were expanded to       
6-well plates and further to T25 flasks. The HAH1 expression levels were measured by 
Western Blot analysis, and the cell line (H22) with the highest expression levels was 
chosen for the NMR experiments. 
 
Cell culture and transient transfection 
HEK293T and HAH1 stably-transfected HEK293T cells were maintained in Dulbecco’s 
Modified Eagle’s medium (DMEM; high glucose, Gibco) supplemented with               
L-glutamine (Gibco), antibiotics (penicillin and streptomycin) (Gibco) and 10% FBS 
(Gibco) in uncoated 75-cm
2
 plastic flasks and incubated at 37 °C, 5% CO2 in a 
humidified atmosphere. Stably-transfected cells were additionally supplemented with 
MEM NEAA (Gibco). Transient transfection was performed by DNA:polyethylenimine 
complex as previously described (13). Cells expressing SOD1 with silenced HAH1 
were obtained by transfection with pHLsec-SOD1 and the three silencing vectors 
(3:1:1:1 ratio); unsilenced cells expressing SOD1 were obtained by transfection with 
pHLsec-SOD1 and empty pHLsec (1:1 ratio); control cells not expressing SOD1 were 
transfected as above, by replacing pHLsec-SOD1 with empty pHLsec. The total DNA 
was kept constant at 25 µg / 75 cm
2
 flask in all experiments. [U-
15
N]-BioExpress 6000 
medium (Cambridge Isotope Laboratories) was used for 
15
N labeling. Cell samples 
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expressing SOD1 were supplemented with 10 μM ZnSO4 starting at the time of 
transfection. 
 
Western Blot and protein quantification 
Protein content was measured by Western Blot analysis. HAH1 was stained with a 
rabbit monoclonal anti-HAH1 antibody (Abcam: ab154179, diluted to 53.2 ng/mL). 
GAPDH was used as reference (rabbit polyclonal anti-GAPDH antibody, Abcam: 
ab9485, diluted at 1:2,000). Goat anti-rabbit IgG (whole molecule)-peroxidase 
secondary antibody (Sigma:A0545) was used, diluted at 1:80,000. For detection, 
LiteAblot EXTEND chemiluminescent substrate (EuroClone) was used. Purified 
recombinant HAH1 was used as standard for the quantification. HAH1 (GenBank: 
NP_004036.1) was expressed with a 6-His tag at C-terminal part in E. coli BL21(DE3) 
gold competent cells for 4 h at 37 °C. After cell lysis, a first purification step was 
performed using a HiTrap chelating (GE Healthcare) column charged with Zn(II). The 
protein was eluted in 20 mM Na2HPO4, 0.5 M NaCl, 5 mM Imidazole, 20 mM EDTA, 
pH=8, buffer. After buffer exchange and digestion with Factor Xa protease (New 
England Biolabs) for 24 hr at 25 °C, the protein was separated from the affinity tag in 
the HiTrap column charged with Zn(II).  
 
Real-time PCR 
Total RNA (1 µg) was extracted from cells using TRI Reagent® (Sigma-Aldrich) and 
reverse-transcribed by the employment of high-capacity cDNA reverse transcription kit 
(Applied Biosystems), according to the manufacturer’s instructions. Quantification of 
the mRNA level of target genes was performed by Real-Time PCR using TaqMan® 
gene expression assays with the automated ABI Prism 7700 sequence detector system 
(Applied Biosystems) as previously described (34). Samples were run in triplicate in 
Micro-Amp optical 96-well plates (Applied Biosystems) with a TaqMan Universal PCR 
Master Mix (Applied Biosystems). Simultaneous amplification of the target sequence of 
HAH1 (Hs01076125_m1, FAM
TM
-MGB dye) together with the housekeeping gene, 
human ACTB (beta-actin) (Applied Biosystems Endogenous Control VIC®/TAMRA™ 
Probe) was carried out with the following profile: initial denaturation for 10 minutes at 
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95 °C, followed by denaturation for 15 seconds at 95 °C and primer annealing and 
elongation at 60 °C for 1 minute for 40 cycles. The results were analyzed by ABI Prism 
Sequence Detection System software (version 1.7; Applied Biosystems).                    
The 2^(-∆∆CT) method was used as a comparative method of quantification (35). 
The data are reported as mean ± SEM of 2^(-∆∆CT) of samples run in triplicate; 
statistical analysis was performed by One-way ANOVA followed by Bonferroni post-
hoc test (*p<0.05). 
 
NMR experiments 
NMR experiments on cells and lysates were acquired at a 950 MHz Bruker Avance 
spectrometer equipped with a TCI CryoProbe. 1D 
1
H (zgesgp Bruker pulse sequence) 
and 2D 
1
H-
15
N SOFAST HMQC spectra (36) were acquired at 308 K. The total 
acquisition time for each cell sample was about 1 h (64 scans, 128 increments) or 1.5 h 
(96 scans, 128 increments). The supernatant of each cell sample was checked in the 
same experimental conditions to exclude protein leakage. The same NMR spectra were 
also acquired on the cell lysates. All the spectra were processed with Bruker Topspin 
software. To eliminate the signals arising from unspecific 
15
N labeling of the cells, the 
2D 
1
H-
15
N SOFAST HMQC spectra of the cell lysates were further processed by 
subtracting the spectrum of a lysate from untransfected cells, acquired in the same 
experimental conditions and identically processed. 
 
Results 
Stable HAH1 cell line characterization 
HEK293T cell lines stably expressing human HAH1 were obtained from single colonies 
of cells transfected with the HAH1 and the integrase genes, after antibiotic selection, 
and the relative expression levels of HAH1 in each cell line were assessed by Western 
Blot analysis and SDS-PAGE (Fig. 1a). The cell line in which HAH1 reached the 
expression levels suitable for in-cell NMR experiments was selected (HEK293T-
HAH1-22, H22 hereafter, Fig. 1b). The effective concentration of HAH1 in a NMR 
sample of H22 cells was ~45 µM, as estimated by 1D 
1
H NMR by comparing the signal 
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intensity between 0.1 and −0.2 ppm in the cell lysate spectrum with an in vitro sample 
of recombinantly expressed HAH1 at known concentration (Fig. 2a). The amide 
crosspeaks arising from [U-
15
N]-labeled HAH1 in a sample of H22 cells grown in      
[U-
15
N]-labeled medium were detected in the 
1
H-
15
N correlation NMR spectra of both 
cells and lysate, showing that stably transfected cells can reach constitutive proteins 
levels sufficient for detection by heteronuclear in-cell NMR (Fig. 2b,c and Fig. S1a,b). 
The chemical shifts of the detected crosspeaks corresponded to those previously 
assigned on [U-
15
N]-apo-HAH1 in vitro (Fig. S1c) (26).  
 
Transient transfection of the second protein gives poor labeling selectivity 
A sequential expression strategy was tested, in which H22 cells were transiently 
transfected with the gene of a second protein, and the unlabeled medium was replaced 
with [U-
15
N]-labeled medium at the time of transfection. SOD1 was chosen as a test 
case for globular proteins that are easily detected by in-cell NMR (5, 11, 13); 
thioredoxin 1 (TRX1) was chosen to represent globular proteins that cannot be detected 
by in-cell solution NMR without recurring to deuterium enrichment, due to extensive 
weak interactions with the cellular environment (20, 24, 37). In either case, transient 
transfection did not decrease the levels of stably expressed HAH1, and the 
overexpressed protein reached the same levels as previously observed in the parental 
HEK cells (13, 24). However, signals arising from 
15
N-labeled HAH1 were still being 
detected in the resulting in-cell NMR spectra (Fig. 3a,b and Fig. S2a,c) and in the 
corresponding lysates (Fig. 3c,d and Fig. S2b,d), due to HAH1 being still synthesized in 
the [U-
15
N]-labeled medium, together with the second protein. 
  
Silencing of HAH1 reduces the rate of protein synthesis 
To avoid the unwanted labeling of HAH1 during the expression of the second protein, 
the rate of HAH1 synthesis needs to be reduced after transfection. Gene silencing by 
RNA interference (RNAi) is a widely used technique to knock-down gene expression in 
mammalian cells. With that purpose, a silencing vector was used to transcribe 
sequences of short hairpin RNA (shRNA) complementary to different regions of the 
HAH1 mRNA. Three different sequences were individually cloned in the silencing 
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vector (Fig. 4a). The silencing vector was co-transfected with the gene of the second 
protein. The relative levels of HAH1 mRNA and protein were measured at different 
times after transfection by RT-PCR and Western Blot, respectively. Efficient silencing 
was achieved by mixing together the three shRNA-encoding sequences (Fig. 4b). When 
comparing the levels of mRNA with those of HAH1 protein as a function of time after 
transfection, it was observed that the protein levels decreased much slower than those of 
mRNA, indicating that the protein turnover rate is low enough to permit the expression 
of the second protein in the time-frame following transfection, without compromising 
the level of HAH1 (Fig. 4c and Fig. S3).  
 
Silencing combined with timed medium switch improves the labeling selectivity 
A temporal window was identified, during which the levels of HAH1 mRNA had 
reached a minimum, while the HAH1 protein levels did not decrease excessively      
(Fig. 4c). Specific labeling of the second protein could be performed during that 
window with minimal unwanted labeling of HAH1. To test this procedure, H22 cells 
were transfected with either SOD1 or the empty vector together with the vectors 
encoding the shRNAs against HAH1, and were kept in unlabeled medium for 14 h 
followed by 16 h in        [U-
15
N]-medium (Fig. 5 and Fig. S4). Corresponding control 
samples were produced, in which HAH1 was not silenced. The resulting in-cell NMR 
spectra confirmed our expectations: HAH1 signals were almost not detected in the     
1
H-
15
N correlation spectra acquired on both cells (Fig. 5b,d) and lysates (Fig. 5f,h), 
while the 
1
H spectra revealed the presence of unlabeled HAH1 (~80% of the levels of 
unsilenced HAH1, Fig. 5i-l). The relative amounts of total and labeled HAH1 in each 
lysate were estimated from the ratio between the aliphatic 
1
H signal intensities (arising 
from the total HAH1, Fig. 5i-l) and the amide 
1
H-
15
N crosspeak intensities (arising from 
15
N-labeled HAH1, Fig. 5e-h), normalized by the same ratio obtained from a sample of 
purified 
15
N-labeled HAH1. In the “fully” 15N-labeled H22 cell sample (Fig. 2c), ~93% 
of the total HAH1 was labeled, close to the nominal isotopic enrichment of the growth 
medium (U-
15N, 98%). The “14+16” labeling strategy alone, without HAH1 silencing, 
caused ~32% of the total HAH1 to be 
15
N-labeled, while the silencing further increased 
the labeling selectivity as only ~15% of the total HAH1 was 
15
N-labeled, and was 
barely detected by 
1
H-
15
N correlation NMR. 
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Discussion 
HEK293T cells stably expressing HAH1 were co-transfected with two vectors: one 
encoding SOD1, the other containing a shRNA which knocked-down the expression of 
HAH1 by degrading its mRNA via RNAi. 
15
N-labeling of SOD1 was achieved by 
replacing the unlabeled growth medium with 
15
N-labeled medium at a proper time after 
transfection. The optimal timing for medium switch and sample collection after SOD1 
expression was chosen by measuring HAH1 protein and mRNA levels at different time 
points following cell transfection. Since HAH1 has a sufficiently long intracellular half-
life, a time window was identified (between 14 h and 30 h following transient 
transfection) during which the shRNA had degraded the HAH1 mRNA, so that the rate 
of HAH1 synthesis was greatly decreased, while its cellular protein content was not yet 
decreased below the concentration required for in-cell NMR (Fig. 4c). During this time 
window, SOD1 was transiently overexpressed and selectively 
15
N-labeled with respect 
to HAH1.  
The strategy described above combines stable and transient protein expression to allow 
two (and in principle more) proteins to be overexpressed in human cells at different 
times. Without any protein expression control mechanism, the stably expressed protein 
would still be produced by the cells after the expression of the second protein has 
started, resulting in poor labeling selectivity, which is critical for proper interpretation 
of the NMR spectra. Our strategy exploits the RNAi machinery of the cells to control 
the rate of protein expression as a function of time (31, 32). For the same purpose, other 
methods may be used, such as the employment of synthetic small interference RNA 
(siRNA) molecules instead of shRNAs (38), however these approaches would require 
the protocol to be adapted to combine DNA transfection with siRNA treatment. 
Alternatively, different strategies could be pursued to control protein expression. 
Inducible gene expression systems, for example the tetracycline-controlled                 
Tet-ON/Tet-OFF systems, are commonly used for that purpose (39–41). Stable cell 
lines could then be created that can overexpress the proteins of interest separately, by 
combining alternative inducible promoters, such as the ecdysone-controlled system 
(42), to the tetracycline-controlled one. However, such strategies would require 
additional vector designing, and may not reach the expression levels required by the 
relatively low sensitivity of NMR spectroscopy.  
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This work shows that controlled protein expression is a useful approach for studying 
protein interactions in human cells by NMR. Although our test proteins were not 
supposed to interact directly, they were useful to assess the labeling specificity and to 
demonstrate the feasibility of our strategy. This method represents an innovative 
approach for studying bona fide interactions between proteins at the atomic level, and in 
principle it can be adapted to different labeling schemes or combined with the existing 
protein-delivery approaches. Hopefully, this work will provide a starting point for 
developing advanced methods that allow finer control of protein synthesis in 
mammalian cells for in-cell NMR applications. 
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Figures 
 
Fig. 1. Stable cell line characterization. (a) Western Blot and SDS-PAGE analysis of 12 
HEK293T-HAH1 cell lines stably expressing HAH1 selected from 36 single colonies 
(H1 – H36) obtained after antibiotic selection; the parental cell line (293T) is shown as 
comparison. (b) Relative HAH1expression levels obtained by normalizing the Western 
Blot intensity by the SDS-PAGE lane intensity; the cell line with the highest expression 
was chosen (H22, marked with an asterisk). 
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Fig. 2. HAH1 stably expressed in human cells can be observed by in-cell NMR. (a) 
Aliphatic region of the 1D 
1
H NMR spectrum of lysed H22 cells (black), showing 
signals arising from stably expressed HAH1. The spectrum of lysed HEK293T cells 
(gray) and the spectrum of purified HAH1 (red) are shown for reference. (b) Selected 
region of the 
1
H-
15
N SOFAST-HMQC spectrum recorded on a sample of [
15
N]-labeled 
H22 cells; (c) Same region as (b) of the 
1
H-
15
N SOFAST-HMQC spectrum recorded on 
the corresponding cell lysate. The amide crosspeaks arising from HAH1 are labeled 
according to the resonance assignment. The spectrum in (c) was further processed to 
subtract the cellular background. See also Fig. S1. 
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Fig. 3. Transient expression and labeling of the second protein causes partial labeling of 
the stably expressed HAH1. Selected region of 
1
H-
15
N SOFAST-HMQC spectra of H22 
cells (a,b) and the corresponding lysates (c,d) transiently transfected either with SOD1 
(a,c) or with TRX1 (b,d). The cells were collected either 24 h (a,c) or 48 h (b,d) 
following transfection. The amide crosspeaks arising from [
15
N]-labeled HAH1 are 
indicated by red arrowheads. See also Fig. S2. 
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Fig. 4. The expression of HAH1 can be efficiently silenced with shRNA-encoding 
vectors. (a) Schematic representation of the HAH1 gene integrated in the H22 genome; 
from left to right: open reading frame from HAH1 cDNA (salmon), woodchuck 
hepatitis virus post-transcriptional regulatory element (WPRE, light blue), bovine 
growth hormone polyadenylation signal (bGHpA, light green). The recognition sites of 
each shRNA sequence are shown (black bars). (b) Silencing efficiency of each shRNA-
encoding vector, assessed from the relative levels of HAH1 mRNA 24 h after 
transfection. The combination of shRNA vectors (Mix) gives the highest transfection 
efficiency (error bars: SEM) (c) Relative levels of HAH1 mRNA (red circles) and 
HAH1 protein (black squares) as a function of time after transfection, measured by Real 
Time RT-PCR (error bars: SEM) and Western Blot (error bars: SD, n = 3), respectively. 
Trends are qualitatively shown as dashed lines. The timing chosen for expression and 
labeling of the second protein is shown (expression in the white + gray area; labeling in 
the gray area). See also Fig. S3. 
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Fig. 5. HAH1 silencing combined with the appropriate labeling strategy improves the 
labeling selectivity. (a-d) Selected region of 
1
H-
15
N SOFAST-HMQC spectra of four 
samples of H22 cells. Cells were transiently transfected with empty vector (a), shRNA 
mix (b), SOD1 (c) or shRNA mix + SOD1 (d). The [
15
N]-medium was provided after 14 
h, and the cells were collected 30 h following transfection. (e-h) Selected region of     
1
H-
15
N SOFAST-HMQC spectra of the corresponding lysates. The amide crosspeaks 
arising from [
15
N]-labeled HAH1 are indicated by red arrowheads. (i-l) Aliphatic region 
of the 1D 
1
H spectra of the same samples (black); HEK293T lysate (gray) and purified 
HAH1 (red) are shown for reference. See also Fig. S4. 
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Supporting Information: 
Sequential protein expression and selective labeling for in-cell NMR in human cells 
 
Supplementary Figures 
 
Supplementary Figure S1. (a) 
1
H-
15
N SOFAST-HMQC spectrum recorded on a 
sample of [
15
N]-labeled H22 cells; (b) 
1
H-
15
N SOFAST-HMQC spectrum recorded on 
the corresponding cell lysate. The spectrum in (b) was further processed to subtract the 
cellular background; (c) 
1
H-
15
N SOFAST-HMQC spectrum recorded on purified        
[U-
15
N]- HAH1. 
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Supplementary Figure S2. (a,b) 
1
H-
15
N SOFAST-HMQC spectra of H22 cells (a) and 
the corresponding lysate (b) transiently transfected with SOD1 and collected 24 h 
following transfection; (c,d) 
1
H-
15
N SOFAST-HMQC spectra of H22 cells (c) and the 
corresponding lysate (d) transiently transfected with TRX1 and collected either 48 h 
following transfection. 
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Supplementary Figure S3. Levels of HAH1 protein measured by Western Blot at 
different times after transfection of the shRNA vectors. GAPDH was used as reference. 
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Supplementary Figure S4. Selected region of 
1
H-
15
N SOFAST-HMQC spectra of four 
samples of H22 cells and the corresponding lysates transiently transfected with empty 
vector (a,b), shRNA mix (c,d), SOD1 (e,f) or shRNA mix + SOD1 (g,h). The          
[
15
N]-medium was provided after 14 h, and the cells were collected 30 h following 
transfection.  
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2.3 The casein kinase 2-dependent phosphorylation of 
NS5A domain 3 from hepatitis C virus followed by time-
resolved NMR 
 
In order to identify CK2-dependent phosphorylation sites in the sequence of NS5A 
domain 3 (from the HCV-1b-J4 genotype), the reaction between the protein and CK2 
was monitored in vitro by acquiring a series of 
1
H-
15
N SOFAST-HMQC spectra during 
the course of the reaction, which was carried on for 24 h at 303 K. The crosspeaks 
arising from the phosphorylated species were assigned de novo from sets of 3D triple 
resonance NMR experiments acquired on U-
13
C,
15
N-labeled NS5A-D3 samples 
obtained by inactivating the kinase at different times. Upon reaction with CK2, four 
serine residues were unambiguously identified as phosphorylation sites (Ser408, 
Ser401, Ser429 and Ser434). Ser408 was phosphorylated with a higher rate compared to 
the other residues. 
Phosphorylation of S429 and S434 gave rise to two amide crosspeaks for each residue, 
with different buildup curves. As the reaction proceeded, the singly phosphorylated 
species were depleted, as reflected by the decreasing intensity of the corresponding 
crosspeaks. The curves of the intermediate and final species of S434 are compatible 
with a consecutive reaction model. This suggests that other reactions may occur at 
dependence of S434 phosphorylation. A suitable model was not found to explain the 
formation of the intermediate and final species of S429. 
Ser434 is not a canonical phosphorylation site of CK2 because there is not an acidic 
amino acid (E/D) in position +1, +2 or +3 but becomes a secondary phosphorylation site 
if a serine in position +3 is phosphorylated. Interestingly, both S434 and S437 are 
highly conserved among the HCV genotypes and their phosphorylation has been found 
to be critical for the interaction between NS5A and the core protein. Although  
phosphorylation of S437 was not observed in our experimental conditions, a decrease in 
the crosspeak intensity of the residues 435-437 was observed, although no new 
crosspeaks could be identified. This behaviour suggests that, during the reaction with 
CK2, either one species is formed that undergoes conformational exchange phenomena 
or multiple species are formed with different phosphorylation patterns.  
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These results provide a starting point to elucidate the role of phosphorylation in the 
modulation of the viral activity, and in the mechanisms of viral assembly, at the 
molecular level. 
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Background: The Hepatitis C virus (HCV) protein NS5A is involved in viral 
replication and assembly. 
Results: CK2-dependent phosphorylation of NS5A Domain 3 is monitored in vitro by 
time-resolved NMR. 
Conclusions: We unambiguously identified four serines, which are phosphorylated 
with different rates. 
Significance: Phosphorylation of NS5A plays a critical role in the viral assembly 
efficiency and infectivity of HCV. 
Keywords: nuclear magnetic resonance (NMR); phosphorylation; Hepatitis C virus 
(HCV); viral protein; virus assembly; enzyme kinetics; time-resolved NMR; 
intrinsically disordered protein (IDP); post-translational modification (PTM). 
 
Abstract 
Hepatitis C virus (HCV) chronically affects millions of individuals worldwide, and an 
effective vaccine is not available to date. The HCV non-structural protein 5A (NS5A) is 
involved in the formation of the viral RNA replication complex, and plays a critical role 
in the viral assembly pathway. Domain 3 (D3) of NS5A is an unstructured polypeptide 
responsible for the interaction between the replication complex and the core particle 
assembly structure. Casein kinase 2 (CK2) is known to phosphorylate NS5A-D3 at 
multiple sites, which have been largely predicted and only indirectly observed. In order 
to identify the CK2-dependent phosphorylation sites, we monitored in vitro the reaction 
between NS5A-D3 and CK2 by time-resolved NMR. By performing de novo resonance 
assignments on the phosphorylated protein, we could identify unambiguously four 
serine residues as substrates of CK2. The time-dependent phosphorylation curves 
obtained for each site and for the neighboring residues allowed to determine the 
apparent rate constants. One serine (S408) was quickly phosphorylated, while the other 
three (S401, S429, S434) reacted noticeably slower. Additional reactions might occur 
close to the protein C-terminus, which caused a decrease in the NMR signal intensities. 
These results provide a starting point to elucidate the role of phosphorylation in the 
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mechanisms of viral assembly, and in the modulation of the viral activity, at the 
molecular level. 
 
Introduction 
Worldwide, an estimated 130–150 million individuals are infected by the Hepatitis C 
virus (HCV), a member of the Flaviviridae family
1
. In 85% of the cases, the virus is 
able to establish chronic infections, leading to liver cirrhosis, hepatocellular carcinoma 
and liver failure (1,2). Six closely related viral genotypes, classified by sequence 
homology, comprise the HCV genus (3). Genotype 1 is the most abundant worldwide, 
and includes subtypes 1a and 1b (4). There is still no effective vaccine available, and the 
antiviral treatments currently applied show some limitation (5,6). Therefore, a better 
understanding of the molecular mechanisms involved in the HCV life cycle is required 
to develop new antiviral therapies. For this reason, the biology of HCV remains a 
topical research subject (7). 
HCV is an enveloped virus containing a positive-sense, single-stranded RNA genome of 
about 9.6 kb (8). The RNA genome of HCV contains a single large open reading frame 
(ORF), which encodes a polyprotein approximately 3,000 amino acids long. This 
precursor polyprotein undergoes a complex series of co- and post-translational 
proteolytic events, catalyzed by both host and viral proteases, to produce 10 mature 
viral proteins: the virion structural proteins E1, E2 (envelope glycoproteins) and the 
core protein; the viroporin p7 involved in virion assembly/release and the nonstructural 
(NS) proteins NS2, NS3, NS4A, NS4B, NS5A, NS5B, which are involved in both 
genome replication and virion assembly (9,10).  
NS5A is a zinc-binding phosphoprotein lacking enzymatic activity, which binds the 
viral RNA and simultaneously interacts with other HCV proteins such as NS5B and 
with host cell proteins such as the human vesicle-associated membrane protein-
associated protein A (VAPA), thus contributing to the replication complex formation 
(11). In addition, NS5A has been shown to be involved in a variety of cellular 
regulation processes, such as interferon resistance and apoptotic regulation, although the 
precise role of these functions in the HCV life cycle has yet to be defined (12,13). 
                                                          
1
http://www.who.int/mediacentre/factsheets/fs164/en/ 
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NS5A consists of three domains separated by two low complexity sequences (LCS1 and 
LCS2) (14) and an N-terminal amphipathic helix essential for its membrane association 
(15). Domain 1 (D1) comprises a zinc-binding motif, which is essential for RNA 
replication (16) and forms a homodimer with a claw-like shape that can accommodate a 
single strand RNA molecule (17,18). It is also required for the interaction with lipid 
droplets, the organelles where the assembly of infectious particles starts (19). Domains 
2 and 3 (D2, D3) have been shown to be both intrinsically disordered with a propensity 
to form secondary structure elements (20–22). D2 is essential for RNA replication, 
while D3 is thought to be dispensable for that role (23,24). It has been shown, however, 
that D3 is critical in the virus assembly process, as it is required for the interaction 
between NS5A and the core protein (24,25).  
NS5A exists in two forms with slightly different mobility on an SDS-PAGE gel: a 
basally phosphorylated form (apparent molecular mass of 56 kDa) and a 
hyperphosphorylated form (58 kDa) (26,27). Pulse-chase and mutational analysis 
suggested that both phosphorylated forms are produced after completion of the 
proteolytic cleavages at the N- and C-termini of NS5A, and that p58 is the product of 
p56 hyperphosphorylation (26,27). The degree of phosphorylation does not affect NS5A 
localization to the ER membrane (28). Hyperphosphorylation sites have been identified 
in a serine-rich region in LCS1 and in D2, and have been shown to act as negative 
regulators of the RNA replication process (27–30). The cellular kinases that are mainly 
involved in the generation of the p58 form are the α isoform of casein kinase 1 (31) and 
polo-like kinase 1 (32). The basally phosphorylated sites are mainly serine residues 
located in both D2 and D3 (27–30). The basal phosphorylation of D3 plays a critical 
role in the virion assembly, as deletions of part of D3 and/or serine to alanine mutations 
have been shown to impair the production of infectious virions, likely by disrupting the 
interaction with core protein (25,33). It has been shown that casein kinase 2 (CK2) is 
responsible for the basal phosphorylation of D3 in multiple sites, and several CK2 
phosphorylation sites have been identified (34,35). However, with few exceptions, the 
positions of such phosphorylation sites, obtained with combined approaches such as 
mass spectrometry and predictive analysis (30,33,36), have not been unambiguously 
determined.  
In this work, we applied time-resolved NMR spectroscopy to characterize in vitro the 
CK2 phosphorylation pattern of HCV-1b NS5A-D3. High-resolution NMR is an ideal 
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technique to characterize chemical modifications of proteins at the residue level, and 
has been shown to be particularly suited to follow protein phosphorylation events     
(37–40). The amide chemical shifts of an intrinsically disordered protein are extremely 
sensitive to post-translational modifications, such as phosphorylation, that change the 
chemical environment in proximity of the substrate residue (41,42). Moreover, fast 
NMR experiments acquired with sensitive equipment allow protein phosphorylation 
events to be monitored in real time, also in intact cells and extracts (43–45). By time-
resolved in vitro NMR, we unambiguously identified four serine phosphorylation sites 
in NS5A-D3, which react with CK2 at different rates. Interestingly, some sites do not 
have a ‘canonical’ CK2 recognition motif, and had not been predicted previously. 
Finally, our data suggest that additional phosphorylation reactions occur close to the     
C-terminus of NS5A-D3, which could cause either conformational exchange 
phenomena, or the formation of multiple phosphorylated products.  
 
Experimental Procedures 
Expression and purification of isotope enriched NS5A-D3 
The synthetic gene (Eurofins Genomics) encoding NS5A-D3, corresponding to amino 
acids 356–447 of full length NS5A of HCV genotype 1b (strain HC-J4) was cloned into 
the expression vector pET-16b+ between NdeI and BamHI restriction sites and was 
verified by DNA sequencing. The plasmid was transformed in E. coli BL21(DE3) Gold 
competent cells (Agilent Technologies). The cells were grown at 37 °C in minimal 
medium with 
15
N-ammonium sulfate and either 
13
C-glucose or 
12
C-glucose as the sole 
nitrogen and carbon sources to an optical density 0.6. Protein expression was induced 
with 0.5 mM IPTG for 16 hr at 18 °C. NS5A-D3 was purified by affinity 
chromatography using a nickel-chelating HisTrap (GE Healthcare) column; the protein 
was recovered in elution buffer containing 300 mM imidazole. After buffer exchange 
and digestion with Factor Xa protease (New England Biolabs) for 24 hr at 25 °C, the 
protein was separated from the affinity tag in a HisTrap column. The buffer was 
exchanged with phosphate buffer saline (PBS, Abcam), 0.5 mM EDTA, 1 mM DTT, 
pH=7, and the protein was concentrated for NMR analysis.  
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Phosphorylation of NS5A-D3 by CK2 
The phosphorylation reaction was performed on a sample containing 100 µM NS5A-D3 
(either 
15
N-labeled or 
13
C,
15
N-labeled) with 1000 U of CK2 (New England Biolabs) at 
303 K in kinase reaction buffer (20 mM Tris-HCl, 50 mM KCl, 10 mM MgCl2, 1 mM 
DTT, 2 mM ATP, pH=7.3). The samples of 
13
C,
15
N-labeled phosphorylated NS5A-D3 
at different reaction times were prepared by stopping the reaction by inactivating CK2 
at 70 °C for 20 min. 
 
NMR experiments 
 NMR experiments for the sequence-specific resonance assignment of NS5A-D3 were 
acquired at a 900 MHz Bruker Avance spectrometer equipped with a TCI CryoProbe. A 
1
H-
15
N 2D SOFAST-HMQC (46) and a set of BEST triple-resonance 3D experiments  
(HNCO, HN(CA)CO, HNCA, HN(CO)CA, HNCACB, HN(CO)CACB) (47) were 
acquired at 278 K on a sample of unphosphorylated [U-
13
C,
15
N]-NS5A-D3 in PBS 
buffer with 0.5 mM EDTA, 1 mM DTT, pH=7. For the assignment of the 
phosphorylated NS5A-D3, the same 3D experiments were acquired at a 950 MHz 
Bruker Avance spectrometer equipped with a TCI CryoProbe at 278 K on samples of 
[U-
13
C,
15
N]-NS5A-D3, which had been previously incubated with CK2 at different 
times in kinase reaction buffer at 303 K. The resonance assignments at 278 K were 
transferred on the spectra acquired at 303 K with the help of SOFAST-HMQC spectra 
acquired at increasing temperatures. The CK2-dependent phosphorylation of NS5A-D3 
was monitored real-time by NMR at 950 MHz. A 
1
H-
15
N 2D SOFAST-HMQC 
spectrum was acquired at t = 0 on a sample of unphosphorylated [U-
15
N]-NS5A-D3 in 
kinase reaction buffer (pH=7.3). 1000 U of CK2 were then added to the sample, which 
was quickly placed back in the instrument. The reaction was monitored starting from     
t = 7.5 min., with a series of 15 min.-long SOFAST-HMQC spectra for the first 6 hours, 
followed by a series of 60 min.-long SOFAST-HMQC spectra for the next 18 h (until    
t = 24 h). All the spectra were processed with Bruker Topspin software. 
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NMR data analysis 
The NMR spectra were analyzed with the software CARA (Computer Aided Resonance 
Assignment) (48). Crosspeak intensities were integrated at each time point. The curves 
obtained at 15 min. intervals over 6 h were used to analyze the faster events, while the 
curves obtained at 1 h intervals over 24 h were used to analyze the slower events. For 
the latter, the first 6 points were calculated each by summing the intensity over four 
consecutive 15 min. spectra. The reaction curves were fitted in Origin Pro with the 
Nonlinear Curve Fitting tool as single exponential decays/buildups, approximating the 
enzymatic reaction as irreversible first order reactions with the equation: 
        
        1 
           
         2 
For each phosphorylation site, kapp (the apparent rate constant) was calculated by 
globally fitting the curves of the neighboring residues. The buildup curve obtained from 
the overlapped crosspeaks of pS401 and pS408 was fitted afterwards as the sum of two 
exponential buildups, by imposing kapp
S401
 = 0.127 h
-1
 and kapp
S408
 = 1.11 h
-1
. For S429, 
the intermediate species was independently fitted with the equation: 
  
    
     
               3 
where k1 and k2 are the apparent rate constants of two consecutive reactions. The final 
phosphorylated species pS429 was independently fitted with equation 2. For S434, the 
intermediate and the final species were fitted together as consecutive first order 
reactions, respectively with equation 3 and the equation: 
    
 
     
    
        
       4 
Chemical shift perturbations between unphosphorylated and phosphorylated               
[U-
15
N]-NS5A-D3 were calculated as Combined Chemical Shift Difference (CCSD) 
from 
1
H and 
15
N amide chemical shifts measured at 278 K using the formula: 
       
 
 
         
 
 
              5 
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Neighbor-corrected Structural Propensity (ncSP) plots of unphosphorylated and 
phosphorylated [U-
13
C,
15
N]-NS5A-D3 were calculated from the 
15
N, 
13C’, 13Cα, 13Cβ 
secondary chemical shifts measured at 278 K using the ncSPC web tool 
(http://nmr.chem.rug.nl/ncSPC; Tamiola et al., 2010 algorithm) (49). 
 
Results 
NS5A-D3 is an IDP with low secondary structure propensity 
NS5A-D3 (residues 356-447, Fig. 1a) from the HCV-1b HC-J4 strain, was 
recombinantly expressed in E. coli cells, either U-
15
N- or U-
13
C,
15
N-labeled, and 
purified for NMR characterization. The 
1
H-
15
N SOFAST-HMQC spectrum shows poor 
dispersion of the amide chemical shifts, typical of an intrinsically disordered protein 
(IDP, Fig. 1b). The backbone chemical shifts were assigned from a set of 3D triple 
resonance NMR experiments on the U-
13
C,
15
N-labeled protein. The neighbor-corrected 
secondary structure propensity plot was calculated from the secondary chemical shifts, 
and showed that NS5A-D3 has a region with very low α-helix propensity close to the     
N-terminus, whereas the rest of the protein lacks any significant secondary structure 
propensity, as previously reported (Fig. 1c) (50). 
 
CK2 phosphorylates NS5A-D3 on four serine residues with different rates 
The phosphorylation of U-
15
N NS5A-D3 by CK2 was monitored in vitro by acquiring a 
series of 
1
H-
15
N NMR spectra during the course of the reaction, which was carried on 
for 24 h at 303 K. During this time, a number of crosspeaks appeared in a region of the 
spectrum typical of phosphorylated serines/threonines, accompanied by the decrease in 
intensity of some crosspeaks of the unphosphorylated D3 (Fig. 2a). Additionally, 
crosspeaks arising from residues close to the phosphorylated sites shifted during the 
reaction. The crosspeaks arising from the phosphorylated species were assigned de novo 
from sets of 3D triple resonance NMR experiments acquired on U-
13
C,
15
N-labeled 
NS5A-D3 samples at different reaction times. Upon reaction with CK2, four serine 
residues were unambiguously identified as phosphorylation sites: S401, S408, S429, 
S434 (Fig. 2a and Fig. 3). The crosspeaks arising from pS401 and pS408 were 
64 
 
overlapped in the 
1
H-
15
N NMR spectra acquired during the reaction (at 303 K), but were 
well separated at 278 K. Time-dependent phosphorylation curves were obtained for 
each site by integrating the crosspeak intensities of the phosphorylated residue and of 
the neighboring residues at each time point (Fig. 2b-e and Supplementary Fig. 1-4). To 
determine the apparent rate constant for each site (kapp ≅ kcat × [CK2] / KM), the curves 
were fitted with a single exponential decay/buildup approximating the enzymatic 
reactions as irreversible first order reactions. S408 reacted with the highest rate constant 
(kapp
S408
 = 1.11 ± 0.15 h
-1
), and was completely phosphorylated in about 4 h (Fig. 2b and 
Supplementary Fig. 1), while the other serines reacted significantly slower (kapp
S401
 = 
0.127 ± 0.005 h
-1
; kapp
S429
 = 0.178 ± 0.005 h
-1
; kapp
S434
 = 0.191 ± 0.007 h
-1
, Fig. 2c-e and 
Supplementary Fig. 2-4), and were not completely phosphorylated in 24 hours (possibly 
also due to decreased kinase activity and/or ATP depletion). Phosphorylation of S429 
and S434 gave rise to two amide crosspeaks for each residue, with different buildup 
curves (Fig. 2d,e and Fig. 3). As the reaction proceeds, the singly phosphorylated 
species are depleted, as reflected by the decreasing intensity of the corresponding 
crosspeaks. The curves of the intermediate and final species of S434 are compatible 
with a consecutive reaction model (Fig. 2e, k1
S434
 = 0.17 ± 0.01 h
-1
 ; k2
S434
 = 0.092 ± 
0.003 h
-1
), suggesting that other reactions may occur at dependence of S434 
phosphorylation. A suitable model was not found to explain the formation of the 
intermediate and final species of S429 (Fig. 2d) that seem to occur with different rate 
constants (k1
S429
 = 0.71 ± 0.03 h
-1
; k2
S429
 = 0.011 ± 0.001 h
-1 
for the blue curve; kapp
S429
 = 
0.111 ± 0.004 h
-1
 for the red curve).  
 
Phosphorylation of NS5A-D3 does not influence the secondary structure 
The chemical shifts of phosphorylated NS5A-D3 at 278 K were compared to those of 
the non-phosphorylated protein. Phosphorylation only caused small perturbations of the 
amide chemical shifts of the residues close to the phosphorylated serines, while the 
other residues remained unaffected, indicating that no changes in the protein 
conformational features have occurred (Fig. 4a). The neighbor-corrected secondary 
structure propensity plot confirmed this result, as phosphorylation caused no significant 
changes in the calculated structure propensity (Fig. 4b).  
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Discussion 
Previous studies have identified several potential CK2-dependent phosphorylation sites 
in the sequence of NS5A-D3 (29,30,33,36). However, it was not always possible to 
pinpoint the exact position of each site, due to the intrinsically ambiguous nature of the 
prediction-based approaches. Indeed, the type and number of predicted phosphorylation 
sites depends on how the consensus sequence for CK2-dependent phosphorylation is 
defined. Usually, the consensus sequence used to predict CK2 sites requires an acidic 
residue (D/E) at the +3 position (i.e. X-pS/pT-X-X-D/E) (36,51). However, other motifs 
are known to be recognized by CK2 which allow D/E at +1,+2 (i.e. X-pS/pT-X-D/E and 
X-pS/pT-D/E, respectively) and, rarely, at even different positions (52), thereby making 
the predictions less reliable. Moreover, the phosphorylation sites were investigated on 
the NS5A protein from different HCV genotypes. Consequently, different sites were 
predicted to be recognized by CK2 for each genotype. 
The four phosphorylation events monitored here by NMR occur on serine residues. 
Among them, S408 is phosphorylated at the highest rate, has a ‘canonical’ (+3) CK2 
recognition sequence and its phosphorylation is consistent with previously reported data 
on other 1b HCV strains (36). S401 is phosphorylated at a much lower rate and, unlike 
S408, has a ‘non-canonical’ recognition sequence (+1,+2) in the strain analyzed here. 
S401 has been identified before as a CK2 phosphorylation site in other NS5A sequences 
from 1b and 2a HCV strains, in which a +3 recognition sequence was present (30,36). 
S429 has a +1 recognition sequence in this strain and, to our knowledge, has been 
identified here for the first time as a phosphorylation site of NS5A-D3.  
The observed phosphorylation of S434 was somewhat unexpected, as it lacks a proper 
recognition sequence for CK2: the closest following acidic residue is E438 (+4), which 
is rarely the case in CK2 recognition motifs. S434 may be recognized as a secondary 
phosphorylation site of CK2, dependent on the phosphorylation of S437 (X-pS/pT-X-X-
pS/pT). Interestingly, both S434 and S437 are highly conserved among the HCV 
genotypes and their phosphorylation has been found to be critical for the interaction 
between NS5A and the core protein, which serves as a scaffold during the assembly of 
the viral particle (25). Moreover, phosphorylation of S437 has been reported in the 2a 
strain (S457 in 2a JFH-1 genotype) (33,36). While phosphorylation of S437 was not 
observed in our experimental conditions, a decrease in the crosspeak intensity of the 
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residues 435-437 was observed, although no new crosspeaks (shifted due to the 
formation of pS437) could be identified. This behavior suggests that, during the reaction 
with CK2, either one species is formed that undergoes conformational exchange 
phenomena, which would hinder the identification of phosphorylated residues in that 
region, or multiple species are formed with different phosphorylation patterns. 
The basal phosphorylation of NS5A plays a critical role in the virion assembly pathway 
of HCV. Although the exact mechanism is still largely uncharacterized, NS5A is known 
to interact with the core protein at the surface of lipid droplets through phosphorylated 
serines in the D3. Despite the available data, the exact position of several of the reported 
phosphorylation sites is still unknown. Here, we have shown by NMR that CK2 reacts 
in vitro with NS5A-D3 and we have identified unambiguously four sites of 
phosphorylation. The reactions occurred independently of each other and with very 
different speeds, with almost 10-fold difference between the formation of pS408 and the 
others. While the biological significance of such difference is obscure, it can be 
speculated that pS408 acts as a primer for other events, such as interaction with other 
cellular kinases, which may be necessary for the correct protein maturation and 
assembly of the virion. Finally, our data validates the current hypothesis of the 
interaction between NS5A and the core protein, which requires the phosphorylation of 
serines close to the C-terminus of D3, such as S434, in a region conserved among all 
HCV genotypes. Further investigation should focus on the possible concerted action of 
CK2 with other kinases, such as the recently reported c-Abl tyrosine kinase (53), which 
may require NS5A-D3 to first react with CK2 in order to be recognized as a substrate of 
c-Abl. 
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Figures 
 
Figure 1. HCV NS5A-D3 has low structural propensity. (a) Domain organization of 
NS5A. Top, from N- to C-terminus: amphipathic α-helix (light gray); domain 1; low-
complexity sequence (LCS) 1; domain 2; LCS2; domain 3. Bottom, amino acid 
sequence of NS5A-D3. (b) 
1
H-
15
N SOFAST-HMQC spectrum of [U-
15
N]-NS5A-D3 at 
278 K. The sequence-specific resonance assignment is shown. (c) Neighbor-corrected 
Structural Propensity (ncSP) of NS5A-D3 calculated from the 
15
N, 
13C’, 13Cα, 13Cβ 
secondary chemical shifts measured at 278 K; positive and negative values indicate 
propensities for α-helix and β-strand, respectively. 
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Figure 2. CK2-dependent phosphorylation of NS5A-D3. (a) 
1
H-
15
N SOFAST-HMQC 
spectrum (black) of [U-
15
N]-NS5A-D3 at 303 K;
 1
H-
15
N SOFAST-HMQC spectrum 
(red) of the same protein sample after CK2-dependent phosphorylation for 24 h at 303 
K. The crosspeaks shifted during the reaction are labeled according to the assigned 
residues. (b-e) Time-dependent phosphorylation curves of each phosphorylated residue, 
obtained by integrating the crosspeak intensity at each time point. The values are 
normalized on the highest value of the fitting curves. Unreacted species (black squares) 
are fitted with a single exponential decay function (black lines); phosphorylated species 
(red squares) with a single exponential buildup function (red lines); intermediate species 
(blue squares) with a two-exponential function (see Methods). 
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Figure 3. Phosphorylated residues at different reaction times. Detailed view of 
1
H-
15
N 
SOFAST-HMQC spectra acquired on [U-
15
N]-NS5A-D3 at increasing times of CK2-
dependent phosphorylation at 303 K. The crosspeaks arising from phosphorylated 
serines are labeled according to the residue number. 
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Figure 4. Effect of phosphorylation on the conformational properties of NS5A-D3. 
(a) Combined Chemical Shift Difference (CCSD) plot of phosphorylated vs. non-
phosphorylated NS5A-D3 calculated from the 
1
H and 
15
N chemical shifts at 278 K. The 
phosphorylated residues are shown in red; CCSD standard deviation is shown as dashed 
line. (b) Neighbor-corrected Structural Propensity (ncSP) of phosphorylated NS5A-D3 
calculated from the 
15
N, 
13C’, 13Cα, 13Cβ secondary chemical shifts at 278 K. Due to the 
shift induced by the phosphate moieties, 
13Cα and 13Cβ of the phosphorylated residues 
were not included in the calculation.  
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The casein kinase 2-dependent phosphorylation of NS5A domain 3 from hepatitis 
C virus followed by time-resolved NMR 
 
Supplementary Figures 
  
79 
 
 
 
 
 
 
80 
 
Supplementary Figure 1. Time-dependent reaction curves of the residues in proximity 
of (and including) S408, obtained by integrating the NMR crosspeak intensity at each 
time point. Decreasing signals (arising from the residues of unphosphorylated       
NS5A-D3) are fitted with a single exponential decay function; increasing signals 
(arising from NS5A-D3 phosphorylated at S408) are fitted with a single exponential 
buildup function. The curves were globally fitted to calculate the apparent rate constant 
of S408 phosphorylation (kapp
S408
 = 1.11 ± 0.15 h
-1
). Weak or overlapping crosspeaks 
(not shown) were not included in the analysis. 
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Supplementary Figure 2. Time-dependent reaction curves of the residues in proximity 
of (and including) S401, obtained by integrating the NMR crosspeak intensity at each 
time point. Decreasing signals (arising from the residues of unphosphorylated      
NS5A-D3) are fitted with a single exponential decay function; increasing signals 
(arising from NS5A-D3 phosphorylated at S401) are fitted with a single exponential 
buildup function. The curves were globally fitted to calculate the apparent rate constant 
of S401 phosphorylation (kapp
S401
 = 0.127 ± 0.005 h
-1
). Weak or overlapping crosspeaks 
(not shown) were not included in the analysis. 
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Supplementary Figure 3. Time-dependent reaction curves of the residues in proximity 
of (and including) S429, obtained by integrating the NMR crosspeak intensity at each 
time point. Decreasing signals (arising from the residues of unphosphorylated      
NS5A-D3) are fitted with a single exponential decay function; increasing signals 
(arising from NS5A-D3 phosphorylated at S429) are fitted with a single exponential 
buildup function. The curves were globally fitted to calculate the apparent rate constant 
of S429 phosphorylation (kapp
S429
 = 0.178 ± 0.005 h
-1
). Weak or overlapping crosspeaks 
(not shown) were not included in the analysis. 
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Supplementary Figure 4. Time-dependent reaction curves of the residues in proximity 
of (and including) S434, obtained by integrating the NMR crosspeak intensity at each 
time point. Decreasing signals (arising from the residues of unphosphorylated      
NS5A-D3) are fitted with a single exponential decay function; increasing signals 
(arising from NS5A-D3 phosphorylated at S434) are fitted with a single exponential 
buildup function. The curves were globally fitted to calculate the apparent rate constant 
of S434 phosphorylation (kapp
S434
 = 0.191 ± 0.007 h
-1
). Weak or overlapping crosspeaks 
(not shown) were not included in the analysis. 
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3. Methodological Aspects 
 
3.1 Cell line 
 
Cultured human embryonic kidney 293T (HEK293T) cells were continuously 
propagated in culture flasks for adherent cells, by incubation under controlled 5% CO2 
atmosphere at 37 °C. HEK293T cells have a doubling time of ~24 h, and are propagated 
every 3-4 days by 1:10 dilution and plating on a new flask. This cell line has some 
advantages like to be easy-handling, excellent transfectability and high capacity for 
recombinant protein expression. They maintain unaltered these properties for ~20 
propagation steps, after which a new cell culture is started from a frozen cell stock. 
During cell growth, Dulbecco’s modified Eagle medium (DMEM) is used, 
supplemented with L-glutamine, antibiotics (penicillin/streptomycin) and 10% fetal 
bovine serum (FBS).  
 
Figure 5 HEK293T cells. Reprinted from ATCC website. 
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3.2 Gene cloning 
 
The genes of hMia40, hTrx1 and hGrx1 were cloned into the pHLsec vector (Fig. 6) 
[107].  
 
Figure 6 pHLsec vector map [107]. 
 
This plasmid is optimized for the expression in mammalian cells and contains the 
cytomegalovirus (CMV) enhancer, a chicken beta actin promoter, a Kozak sequence, an 
optimized chicken protein receptor tyrosine phosphatase (RPTP) sigma secretion signal, 
cloning sites, and a rabbit betaglobin polyadenylation (PolyA) sequence. Using the 
EcoR I and Xho I restriction enzymes, the secretion signal sequence was removed 
allowing the native protein to be expressed in the cytoplasm. 
The gene of hHAH1 was cloned in the pURD plasmid between Hind III and Xho I 
restriction enzymes (Fig. 7) [108]. 
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Figure 7 pURD vector map [108]. 
 
pURD vector is optimized for generating stable cell lines. It contains a phiC31 
attachment site (AttB) for site-specific recombination with pseudo AttP sites in the 
mammalian cell genome when the PhiC31 integrase gene (pgk-phiC31/pCB92) is 
cotransfected, and a mammalian cell selection cassette (SV40 promoter, puromycin 
resistance gene, PolyA). The expression cassette contains the same promoter as 
pHLSec, a Woodchuck Hepatitis Virus posttranscriptional regulatory element (WPRE), 
and a bovine growth hormone (BGH) PolyA.  
All the DNA clones were verified by DNA sequencing. DNA was purified using the 
Endotoxin-Free Plasmid Maxi Kit (Macherey-Nagel) in order to ensure successful 
transfection of human cells and protein expression.  
The synthetic gene (Eurofins Genomics) encoding NS5A-D3, corresponding to amino 
acids 356–447 of full length NS5A of HCV genotype 1b (strain HC-J4), was cloned into 
the expression vector pET-16b+ between Nde I and BamH I restriction sites. The     
pET-16b+ vector contains a T7 promoter for expression in bacterial cells and carries an 
N-terminal His-Tag sequence followed by a Factor Xa site (Fig. 8). 
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Figure 8 pET1-6b+ vector map. Reprinted from http://www.helmholtz-
muenchen.de/fileadmin/PEPF/pET_vectors/pET-16b_map.pdf 
 
3.3 DNA transfection in mammalian cells 
 
Transfection is the process of introducing nucleic acids (such as supercoiled plasmid 
DNA or siRNA constructs) into the cells. There are various methods of introducing 
foreign DNA into a eukaryotic cell: some rely on physical treatment (electroporation, 
cell squeezing, nanoparticles), other on chemical materials or biological particles 
(viruses) that are used as carriers. A very affordable and highly efficient transfection 
reagent is polyethylenimine (PEI) [109, 110]. A large selection of PEI forms is 
available, varying in molecular weight and branching. The employed PEI is ‘25 kDa 
branched’, which was found to be most effective in transfecting various cells lines with 
minimal cytotoxic effects [111]. Stock solutions are made in water, first at 100 mg ml
-1
 
(PEI is an extremely viscous liquid). Once the solution is homogeneous, it is further 
diluted to 1 mg ml
-1
, the pH adjusted to 7 with HCl, filter sterilized and aliquoted.  
PEI is a polycationic reagent that forms large complexes with the negatively charged 
DNA and promotes the binding of the complex to anionic proteoglycans that are present 
on the cell surface. Through endocytosis, the DNA/PEI complex enters into the cells, 
where the DNA is released and it migrates to the nucleus (Fig. 9). The DNA 
transfection can be transient or stable. In the case of stable transfection, the exogenous 
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DNA is integrated into cell genome and it remains also in daughter cells. In transient 
transfection, the transfected genetic material is only transiently expressed. Since the 
DNA introduced in the transient transfection process is not integrated into the nuclear 
genome, the foreign DNA will be diluted through mitosis or degraded. 
 
Figure 9 Schematic representation of PEI-mediated DNA transfection of mammalian cells. Adapted from 
http://www.nano-lifescience.com. 
 
 DNA transient transfection  
To perform transient transfection, optimal conditions are when adherent cells reach 
about 90% confluency and a mixture of DNA and PEI in 1:2 ratio (w/w) is used [107]. 
For a standard 75 cm
2 
flask, 25 µg of plasmid DNA are required. The DNA is added to 
2.5 ml serum-free medium and is followed by the addition of 50 µg PEI and gently 
mixed. During complex formation, media from the plates to be transfected should be 
changed, lowering the serum concentration to 2%. Finally, the DNA–PEI complex is 
added to the dish, which is then briefly rotated to allow mixing and the cells are placed 
in the incubator. For co-expression of two proteins, the amount of DNAs can be varied 
to obtain different expression levels for each protein (the expression level is not linear 
with the DNA amount).  
 
 DNA stable transfection 
To produce stably transfected cell lines, parental 293T cells were transfected with the 
pURD vector containing the HAH1 cDNA together with the PhiC31 integrase gene 
[112]. Once they reached ~100% confluence, stable cell line selection was performed by 
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treating the cells with 2 µg/ml puromycin for 10 days, replacing the growth medium 
every 3-4 days to remove dead cells, until cell clumps (single colonies) were visible. 
Single colonies were manually picked from the dish and individually seeded 96-well 
plate wells. During the following days, growing colonies were selected by manual 
inspection and seeded to 12-well plates. Lines were selected based on the growth rate, 
and were expanded to 6-well plates and further to T25 flasks. The HAH1 expression 
levels were measured by Western Blot analysis. 
 
3.4 Gene silencing in mammalian cells 
 
RNA interference (RNAi) is a biological process of silencing gene expression in a range 
of organisms (reviewed in [113]). The silencing of a gene is a consequence of 
degradation of double-stranded RNA into short RNAs that activate ribonucleases to 
target homologous mRNA. The resulting phenotypes either are identical to those of 
genetic null mutants or resemble an allelic series of mutants. Extensive genetic and 
biochemical analysis revealed a two-step mechanism of RNAi-induced gene silencing. 
The first step involves degradation of dsRNA into small interfering RNAs (siRNAs),  
21 to 25 nucleotides long, by Dicer protein. In the second step, the siRNAs join an 
RNase complex, RISC (RNA-induced silencing complex), which acts on the cognate 
mRNA and degrades it. RNAi has been associated with regulatory processes such as 
antiviral defense mechanisms and gene regulation.  
RNAi could be induced in cultured cells with exogenous RNA by directly transfection 
with siRNA or with a plasmid that encodes for a short hairpin RNA (shRNA). Because 
siRNA is composed of RNA and it is inherently fragile, it is 99% degraded after 48 
hours while shRNA is expressed for up 96 hours. This means also that a higher dose of 
siRNA is required respect to the plasmid that generates shRNA. For these reasons, 
pSilencer 2.1-U6 hygro siRNA Expression vector (Life Technologies) was used       
(Fig. 10).  
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Figure 10 pSilecer 3.1-H1 hygro vector map. 
 
The pSilencer 2.1-U6 hygro vector employs a human U6 RNA polymerase III (pol III) 
promoter that generates large amounts of small RNA across a variety of cell types     
[114, 115]. The terminator consists of a short stretch of four uridines; this is compatible 
with the original siRNA design that terminates with a two uridine 3’ overhang. An 
efficient approach is to express a single RNA that is a 21-mer hairpin sequences specific 
to the mRNA target, a loop sequence separating the two complementary domains, and a 
polyuridine (Fig. 11).  
 
Figure 11 Hairpin siRNA 
 
The 21-mer template oligonucleotide is calculated entering siRNA target sequence into 
the web-based insert design tool 
(www.ambion.com/techlib/misc/psilencer_converter.html) and the loop sequence is    
5’-CGAA-3’. Near the end of the hairpin siRNA template is a 6 nucleotide poly(T)-tract 
recognized as a termination signal by RNA pol III that will terminate RNA synthesis. 
For each target gene, two complementary oligonucleotides are designed with 5' 
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noncomplementary ends that form the BamH I and Hind III restriction site overhangs 
upon annealing. The pSilencer siRNA Expression Vectors was linearized with both 
BamH I and Hind III to facilitate directional cloning.  
Three sequences of shRNA were designed to perform silencing of HAH1: one targets 
the HAH1 open reading frame (sense strand 5’-ACGAGTTCTCTGTGGACATGA-3’), 
while other two target the unique UTR elements WPRE                                                         
(5’-GCAATCAACCTCTGGATTACA-3’) and BGH                                                   
(5’-GGAAGACAATAGCAGGCATGC-3’) that are present in the pURD vector. This 
three shRNA were produced into the cells by transient transfection of pSilencer vectors. 
Transcription and expression of the HAH1 gene were monitored respectively by       
RT-PCR and Western Blot.  
 
3.5 Protein expression in mammalian cells 
 
Protein expression in HEK293T cells was carried out in 48 hr and the cells were 
incubated under controlled 5% CO2 atmosphere at 37 °C. For unlabeled cell samples 
conventional DMEM medium was used; BioExpress® 6000 (CIL) was used for uniform 
15
N labeling.  
To perform sequential and selective labeling, the expression was carried out in 30 hr:  
14 hr in unlabeled medium and further 16 hr in U-
15
N medium. 
Metal ions can be added to expression medium when they are necessary for maturation 
or activation of overexpressed protein. When hSOD1 was expressed, Zn(II) was 
supplemented as ZnSO4 in the medium to a final concentration of 10 µM immediately 
after the transfection. To ensure complete activation of Trx1, sodium selenite was 
supplemented to a final concentration of 100 nM both in culture medium starting 24 hr 
before transfection and in expression medium. 
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3.6 In-cell NMR sample preparation 
 
To prepare the NMR sample, HEK293T cells from a 75 cm
2
 culture flask were detached 
by incubation with trypsin-EDTA 0.05%, and washed in phosphate buffered saline 
(PBS) through gentle centrifugation (800 x g). Cells were re-suspended in 180 µl of 
NMR buffer (DMEM supplemented with 70 mM HEPES, 65 mM Glucose, 20% (v/v) 
D2O) and pipetted in a 3 mm Shigemi NMR tube. Cells were sedimented to the bottom 
with the help of a manual centrifugation device. 
After the NMR experiments, cells were re-suspended in their supernatant and pelleted 
again out of the tube. The supernatant was checked by NMR for protein leakage. Cells 
were lysed by the freeze-thaw method in 150 µl of PBS buffer supplemented with      
0.5 mM EDTA and Pefabloc. After centrifugation at 16,000 x g for 60 min at 4 °C, the 
cleared cell extract was recovered for NMR and SDS-PAGE analysis.  
 
3.7 NMR experiments 
 
During in-cell NMR experiments, it is fundamental to limit cell death and disruption. A 
way to overcome this problem is to reduce acquisition time using fast recycling NMR 
experiments. 
In-cell NMR experiments (1D 
1
H and 2D 
1
H-
15
N SOFAST-HMQC) were acquired at 
305 K and 308 K using a 950 MHz Bruker Avance III spectrometer equipped with a   
CP TCI CryoProbe. The use of SOFAST sequence allows having a total acquisition 
time ranged from 1 to 2 hr. 
 
 1D 1H NMR spectra 
1
H NMR spectra were used to check protein overexpression over other cellular 
components. In fact, a set of protein signals falls in the aliphatic region from -1 to         
1 ppm of 1D spectrum that is free from cellular background. Spectrum of cellular 
background was obtained transfecting the cells with empty vector. In the case of Mia40, 
the 
1
Hγ peak of Ile 53 at -0.7 ppm is a marker of the folded conformation of Mia40. The 
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effective concentration of HAH1 in a NMR sample of stable transfected cells was 
estimated by 1D 
1
H NMR by comparing the signal intensity between 0.1 and -0.2 ppm 
in the cell lysate spectrum with an in vitro sample of recombinantly expressed HAH1 at 
known concentration. 
 
 2D 1H-15N SOFAST-HMQC 
Fast data acquisition in SOFAST-HMQC is realized by using very short inter-scan 
delays. SOFAST-HMQC combines the advantages of a small number of radio-
frequency pulses, Ernst-angle excitation, and longitudinal relaxation optimization to 
obtain an increased signal to noise ratio for high repetition rates of the experiment. 
The main features of SOFAST-HMQC are the following: (i) the HMQC-type H–X 
transfer steps require only few radio-frequency pulses, which limit signal loss due to 
B1-field inhomogeneities, and pulse imperfections. A reduced number of radio-
frequency pulses become important if the experiment is performed on a cryogenic 
probe, where B1-field inhomogeneities are more pronounced. (ii) The band-selective 
1
H 
pulses reduce the effective spin-lattice relaxation times (T1) of the observed 
1
H spins. 
The presence of a large number of non-perturbed 
1
H spins, interacting with the observed 
1
H via dipolar interactions (NOE effect), significantly reduces longitudinal relaxation 
times and the equilibrium spin polarization is more quickly restored. (iii) The adjustable 
flip angle of the 
1
H excitation pulse allows further enhancement of the available steady-
state magnetization for a given recycle delay The performance of SOFAST-HMQC 
critically depends on the choice of the pulse shapes for the band-selective excitation and 
refocusing pulses on the 
1
H channel [116].   
 
3.8 Assessment of cell viability  
 
Cell viability before and after each in-cell NMR experiment was estimated by staining 
with trypan blue. The trypan blue dye selectively stains damaged or dead cells, as is 
able to diffuse through damaged cell membranes, and accumulates in the cytoplasm. 
Conversely, the plasma membrane of live cells is not permeable to the dye. The aliquots 
of cells are diluted and incubated with trypan blue. They are laid on a Burker chamber 
95 
 
and counted under phase-contrast microscope. On average, cell viability always 
remained above 90% after NMR experiment. 
 
3.9 Western blotting 
 
The Western Blot is an analytical technique used to identify specific proteins in a 
sample of cells or extract. The mixture of proteins was separated through gel 
electrophoresis. The proteins were then immobilized on a nitrocellulose membrane 
following electrophoretic transfer from the gel. Non-protein binding areas on the 
membrane were blocked with non-fat milk or BSA to prevent any non-specific binding 
of antibodies. The membrane was first incubated with a primary antibody that 
specifically binds to the target protein and then with a secondary antibody conjugated 
with a reporter used for the detection. Chemiluminescent detection method was used. It 
is based on secondary antibody conjugated with horseradish poroxidase (HRP) enzyme. 
On the addition of a peroxide-luminol mixture, the HRP enzyme catalyses the oxidation 
of luminol, which is accompanied by blue-green luminescence. The light was detected 
by CCD cameras that capture a digital image of the western blot. The detected signal is 
proportional to the amount of protein and a quantitative analysis was performed by 
densitometry using ImageJ program. 
 
3.10 Proteins purification 
 
 hMia40 
Unlabeled and U-
15
N labeled sample of hMia40 for in vitro interaction with hMia40 and 
for Western Blot analysis was produced as follows: a cell culture of E. coli BL21(DE3) 
Gold competent cells transformed with pDEST-His-MBP plasmid containing the 
hMia40 gene, was grown overnight at 37 °C in 40 ml LB, harvested and re-suspended in 
2 L of LB or 
15
N-labeled M9 medium. Protein expression was induced with 0.7 mM 
IPTG for 16 hr at 25 °C. hMia40 was purified by affinity chromatography using a nickel 
chelating HisTrap (GE Healthcare) column; the protein was eluted in 500 mM 
imidazole. hMia40 was then cut from MBP by incubation with AcTEV protease O/N at 
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25 °C, and separated from His-tagged MBP with a second purification step using Ni-
chelating resin. Finally, two size-exclusion chromatography steps were performed to 
obtain pure hMia40. The sample buffer was then exchanged with 50 mM potassium 
phosphate, 0.5 mM EDTA, 1 mM DTT, pH=7 to perform NMR experiment. Reduction 
of the structural disulfide bonds of hMia40 was performed by incubating hMia40 at    
95 °C 10 min with 10 mM DTT in phosphate buffer. 
 
 hGlutaredoxin 1 
hGlutaredoxin 1 for in vitro interaction with hMia40 and for Western Blot analysis was 
produced as follows: a pTH34 vector containing the human Grx1 gene (N-term fused 
with His-tag and TEV recognition site) was transformed in E. coli BL21(DE3) Gold 
competent cells. A cell culture was grown overnight at 37 °C in 10 ml of LB, harvested 
and re-suspended in 1 L of minimal medium M9. Cells were grown at 37 °C until    
O.D. 0.6 and protein expression was induced with 0.5 mM IPTG for 16 h at 25 °C. 
hGrx1 was purified by affinity chromatography using a nickel chelating HisTrap (GE 
Healthcare) column. The fractions containing pure hGrx1 (checked by SDS-PAGE) 
were digested with AcTEV protease (Invitrogen) O/N at 25 °C. The protein was 
separated from the affinity tag in a HisTrap column. The sample buffer was then 
exchanged with 50 mM potassium phosphate, 0.5 mM EDTA, pH=7.  
 
 hThioredoxin 1 
Pure hThioredoxin 1 for Western Blot analysis was prepared from HEK293T cells 
overexpressing Trx1. Cells were lysed by the freeze-thaw method in 20 mM potassium 
phosphate buffer (pH=7). After centrifugation at 16,000 x g for 60 min at 4 °C, the 
cleared cell extract was incubated at 70 °C for 4 min to remove contaminating proteins. 
After centrifugation (30 min at 16,000 g), Trx1 was purified by anionic exchange 
chromatography using a HiTrap™ DEAE FF (Amersham Biosciences) column applying 
a linear gradient of potassium phosphate buffer (10 to 100 mM, pH=7). The fractions 
containing pure hTrx1 were identified by SDS-PAGE. 
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 hHAH1 
Pure hHAH1 was produced as follows: a pET21a vector containing the human HAH1 
gene (C-term fused with Factor Xa recognition site and His-tag) was transformed in E. 
coli BL21(DE3) Gold competent cells. A cell culture was grown overnight at 37 °C in 
20 ml LB, harvested and re-suspended in 1 L of LB. Protein expression was induced 
using 1 mM IPTG when O.D. 0.6 and the cells were harvested 4 hr thereafter. After cell 
lysis, a first purification step was performed using a HiTrap chelating (GE Healthcare) 
column previously charged with Zn(II). The protein was eluted with the 20 mM 
Na2HPO4, 0.5 M NaCl, 5 mM Imidazole, 20 mM EDTA, pH=8. After buffer exchange 
and digestion with Factor Xa protease (New England Biolabs) for 24 hr at 25 °C, the 
protein was separated from the affinity tag in a HisTrap column charged with Zn(II). 
The fractions containing pure hHAH1 were identified by SDS-PAGE. 
 
 NS5A-D3 
Pure NS5A-D3 for in vitro phosphorylation by CK2 was prepared as follows: a 
pET16b+ containing the gene of NS5A-D3 was transformed in E. coli BL21(DE3) Gold 
competent cells. A cell culture was grown overnight at 37 °C in 40 ml LB, harvested 
and re-suspended in 2 L of 
15
N or 
13
C/
15
N M9 medium. The cells were grown at 37 °C 
to an optical density 0.6. Protein expression was induced with 0.5 mM IPTG for 16 hr at 
18 °C. NS5A-D3 was purified by affinity chromatography using a nickel-chelating 
HisTrap (GE Healthcare) column; the protein was recovered in elution buffer containing 
300 mM imidazole. After buffer exchange and digestion with Factor Xa protease (New 
England Biolabs) for 24 hr at 25 °C, the protein was separated from the affinity tag in a 
HisTrap column. The buffer was exchanged with phosphate buffer saline (PBS, 
Abcam), 0.5 mM EDTA, 1 mM DTT, pH=7, and the protein was concentrated for NMR 
analysis.  
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3.11 In vitro phosphorylation of NS5A-D3 by CK2 
 
The in vitro phosphorylation reaction of NS5A-D3 was performed on a sample 
containing 100 µM of the protein (either 
15
N-labeled or 
13
C,
15
N-labeled) with 1000 U of 
CK2 (New England Biolabs) at 30 °C in 20 mM Tris-HCl, 50 mM KCl, 10 mM MgCl2, 
1 mM DTT, 2 mM ATP, pH=7.3. The samples of 
13
C,
15
N-labeled phosphorylated 
NS5A-D3 at different reaction times were prepared by stopping the reaction by 
inactivating CK2 at 70 °C for 20 min. 
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4. Conclusions  
 
During my PhD studies I applied the in-cell NMR approach to investigate redox-
dependent protein folding processes in living cells. In particular, I characterized the 
folding and redox state of the mitochondrial protein Mia40 in the cytoplasm of living 
human cells. We found that the folded form of Mia40, which cannot be imported into 
mitochondria, is accumulated in the cytoplasm, suggesting that there is the need for a 
mechanism to keep cytoplasmic Mia40 reduced until it reaches the outer mitochondrial 
membrane. By increasing the expression levels of two cytoplasmic thiol-disulfide 
oxidoreductases, Grx1 and Trx1, we showed that Mia40 was mostly reduced, indicating 
that the folding of Mia40 is controlled by these cytoplasmic redox-regulation systems, 
Grx1 having a stronger effect than Trx1. Conversely, this effect was not observed in in 
vitro experiments suggesting that the effect of Grx1 on oxidation state of intracellular 
Mia40 is mediated by other components of the cytoplasm. These results show the 
relevance of NMR studies performed in living cells, which provide a way to describe 
cellular physiological processes at atomic resolution, and to understand how the 
proteins involved are affected and regulated by such processes.  
In-cell NMR is an ideal approach for the characterization of protein-protein interactions. 
In order to extract meaningful information from heteronuclear in-cell NMR spectra, 
only one protein needs to be detectable and/or labeled.  Currently, methods that allow 
expressing two or more proteins at different times and with different labeling have been 
developed only in E. coli cells. To extend this approach to mammalian cells, we 
designed and optimized a new protocol combining stable and transient transfection with 
gene silencing, to allow the sequential expression of two proteins, with only one being 
selectively labeled. With this method, we provide a useful tool for studying interactions 
between two proteins directly inside human cells. In principle, this approach could be 
adapted for the characterization of more than two proteins in combination with existing 
protein-delivery approaches.  
Finally, I contributed to characterize in vitro the CK2-dependent phosphorylation of the 
domain 3 of the viral protein NS5A by time-dependent NMR. We identified 
unambiguously four serines as phosphorylation sites, some of which had not been 
predicted previously. The phosphorylation reactions occurred independently of each 
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other and with different rates. Domain 3 of NS5A is fundamental for the interaction 
with core protein, which is the first step of virion assembly, therefore a better 
understanding of the molecular mechanisms underlying such process is critical for 
future development of new antiviral therapies. Further investigation should focus on 
characterizing the phosphorylation pattern of NS5A-D3 directly in hepatic cells or in 
cellular lysates. Such studies could reveal how the interplay between CK2 and other 
cytoplasmic kinases affect NS5A-D3 phosphorylation and ultimately regulate virion 
assembly. 
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